Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 56549. Отображено 100.
05-01-2012 дата публикации

Anti-inflammatory dissolvable film

Номер: US20120003292A1
Принадлежит: Individual

Provided, among other things, is a slowly dissolvable film comprising: herbal bioactive agent(s); and polymer(s), dissolvable in the aggregate, wherein the film becomes adhesive as it is placed against a mucosal surface and begins to absorb moisture therefrom.

Подробнее
19-01-2012 дата публикации

Traditional chinese medicinal ointment for treating burn, scald and infective trauma and preparative method thereof

Номер: US20120015041A1
Автор: Xinwei Sun
Принадлежит: Individual

This invention is disclosing a pure ointment of traditional Chinese medicine which was invented to treat burn or scald, and infectious trauma, and its preparation. The ointment has solved a number of problems in the treatment of burn or scald, and infectious trauma, such as the high cost of current drugs, post-treatment scar, and unfavorable therapeutic effect. The advantages of this ointment include low cost, favorable therapeutic effect, short course, and without scar after treatment. Its formula is based on the weight of every five hundred portions of following ingredients: lithospermum, 4-10 portions, beeswax, 5-20 potions, insect-white wax, 5-20 portions, and lard, 450-486 portions.

Подробнее
26-01-2012 дата публикации

Garcinia Mangostana L. and Iridoid Based Formulations

Номер: US20120021079A1
Принадлежит: Individual

Embodiments of the invention relate to fortified food and dietary supplement products, which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relate to the administration of products enhanced with Garcinia mangostana L. and iridoids.

Подробнее
01-03-2012 дата публикации

Process of Extracting Isothiocyanates

Номер: US20120052175A1
Принадлежит: Procter and Gamble Co

A process for producing an essential oil. The essential oil can be white mustard essential oil. The white mustard essential oil can include a moisture sensitive isothiocyanate compound. The moisture sensitive isothiocyanate compound can be 4-HBITC. The essential oil can be produced from mustard seed, which can comprise a precursor sinalbin and myrosinase enzyme. The mustard seed can be reduced into a powder. Activation of the myrosinase enzyme by using a water solvent and a promoter to form a slurry can be performed, wherein the myrosinase enzyme catalyzes the production of an essential oil comprising an isothiocyanate from the sinalbin precursor.

Подробнее
05-04-2012 дата публикации

Compositions and Methods for Treatment and Management of Pain

Номер: US20120082739A1
Автор: Reza Ghorbani
Принадлежит: Individual

Disclosed herein are compositions and methods for the treatment and management of pain in a subject, comprising topically or orally administering a therapeutically effective amount of a composition comprising herbal extracts and compound mixtures to a subject. The composition includes turmeric extract, Boswellia extract, ginger extract, holy basil extract, rosemary extract, white willow extract and alpha lipolic acid

Подробнее
24-05-2012 дата публикации

Combination herbal product to benefit respiratory tract in people exposed to smoke

Номер: US20120128801A1
Принадлежит: Aadvantics Pharmaceuticals Inc

An herbal composition for providing a beneficial effect to the respiratory tract. The composition includes Thyme Leaf, Wild Cherry Bark, Cocoa Extract, Mullein Leaf Extract, and Boswellia Serrata . In particular, the composition may prevent or treat cough, specifically caused by exposure to smoke. Also described are methods of using the herbal composition.

Подробнее
28-06-2012 дата публикации

Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof

Номер: US20120164249A1
Принадлежит: Uni President Biotech Co Ltd

A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type of medicinal materials and second type of medicinal materials. The first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type of medicinal materials is one, two or three selected from the group cosisting of Zingiber Officinale, Olibanum and Myrrha. The preparation method for the Chinese herbal medicine composition comprises the following steps: adding the first type of medicinal materials and the second type of medicinal materials into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extratum.

Подробнее
23-08-2012 дата публикации

Spray dried myrosinase and use to produce isothiocynates

Номер: US20120213890A1
Принадлежит: Caudill Seed Co Inc

A spray dried myrosinase/ascorbate mixture is formed from the steps comprising: providing a source of myrosinase, adding ascorbate to the source of myrosinase, heating the source of myrosinase to a temperature of about 104° F. (about 40° C.) or higher, and spray drying the myrosinase/ascorbate mixture. The spray dried myrosinase/ascorbate mixture may be used to prepare isothiocyanates. The spray dried myrosinase/ascorbate mixture may also be mixed with glucoraphanin and used in an activated tablet or capsule.

Подробнее
27-09-2012 дата публикации

Herbal extracts and flavor systems for oral products and methods of making the same

Номер: US20120244084A1
Принадлежит: Individual

The invention provides a method for preparing an herbal extract and a flavor system comprising an herbal extract produced by the process. The invention also provides a flavor system comprising an herbal extract comprising thymol, eugenol, carvacrol and eucalyptol. The invention further provides a flavor system comprising a thyme extract having a minimum inhibitory concentration of less than about 3%. Additionally, the invention provides an oral product comprising a flavor system.

Подробнее
01-11-2012 дата публикации

Primary bile acid and secondary bile acid generation regulator

Номер: US20120276229A1
Автор: Fumitaka Ueda, Yuriko Oda
Принадлежит: Fujifilm Corp

A primary bile acid and secondary bile acid generation regulator of the present invention includes an α-glucosidase activity inhibitor component, preferably a component derived from at least one plant selected from the group consisting of Salacia genus plant, mulberry and Gymnema.

Подробнее
03-01-2013 дата публикации

Composition and method to alleviate joint pain

Номер: US20130005828A1
Принадлежит: US Nutraceuticals LLC

Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.

Подробнее
10-01-2013 дата публикации

Anti-Fever Botanical Composition and Uses Thereof

Номер: US20130011501A1
Принадлежит: Micro Dose Life Sciences LLC

According to at least one aspect of the present invention, a botanical anti-fever composition is provided. In at least one embodiment, the botanical composition comprises a therapeutically effective amount of admixture of parts or extracts of at least one plant species from each of genus Baptista and genus Swertia . In at least one particular embodiment, the botanical composition contains Baptista Tincoria . In at least another particular embodiment, the botanical composition contains Swertia Chirata.

Подробнее
10-01-2013 дата публикации

Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibers

Номер: US20130011902A1

The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. The invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers. The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers.

Подробнее
24-01-2013 дата публикации

Compositions and methods for reducing the incidence of equine digestive disorders

Номер: US20130022576A1
Автор: Jay A. Altman
Принадлежит: Novus International Inc

The present invention encompasses compositions and methods of reducing the incidence of equine digestive disorders.

Подробнее
24-01-2013 дата публикации

Expression Modulator For Clock Gene Bmal

Номер: US20130022635A1
Принадлежит: Shiseido Co Ltd

The present invention provides a substance which can modulate expression of a Bmal gene effectively and with a wide range of application. Provided is an expression modulator for the Bmal gene comprising, as an active ingredient, one or more selected from the group consisting of hinoki cypress extract, chlorella extract, hop extract, Zanthoxylum extract, juniper oil, lavender oil, eucalyptus oil, olibanum, cypress oil, palmarosa oil, pineneedle oil, rose oil, ylang-ylang oil, elemi oil, petitgrain oil, pepper oil, thyme oil and chamomile oil.

Подробнее
28-02-2013 дата публикации

Warming Inch Loss Delivery System

Номер: US20130052275A1
Автор: Michelle Ward
Принадлежит: Individual

This invention is a topical treatment for the skin, used for skin enhancement, firming, smoothing, refining and to reduce the appearance of cellulite; that has a self-warming or thermogenic effect comprised of a base combination of warming herbs (Ayurvedic), being any herbs that create a warming effect, combined with dietary minerals that can be blended together in any ratio.

Подробнее
07-03-2013 дата публикации

Sinonasal Specimen Collection Kit and Use

Номер: US20130060163A1
Автор: James Liu
Принадлежит: Individual

The present invention additionally provides a kit for collecting the sinonasal specimen to analyze which pathogenic microbes cause a disease in a mammal, how to test the drug sensitivity against the infectious microbes in sinonasal cavities, and to help the selection of a pharmaceutical composition to selectively treat a disease of a mammal. The present invention also provides a pharmaceutical composition comprising a chemical compound or a herb extract or the combination having at least one of the activities of antiviral, antibacterial, antifungal, anti-inflammatory, anti-allergy, anti-cancer, promoting membrane healing or immunomodulating, for the treatment and prevention of a disease of a mammal. The invented method of treating a human disease reduces infectious and inflammation without causing antibiotic resistance or clinically noticeable adverse event.

Подробнее
21-03-2013 дата публикации

Oral Formulations For Promoting Cellular Purification

Номер: US20130071369A1
Принадлежит: NSE Products, Inc.

An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation. 1. An oral formulation comprising a plurality of agents that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject , wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants , and at least one gene encoding cellular detoxifiers , and wherein at least one of the plurality of agents attenuates inflammation.2. The oral formulation of claim 1 , wherein the Nrf2-associated genes are selected from the group consisting of NFE2L2 claim 1 , GCLM claim 1 , GCLC claim 1 , GSR claim 1 , GSTA1 claim 1 , GPX1 claim 1 , GPX4 claim 1 , HMOX1 claim 1 , NQO1 claim 1 , SRXN1 claim 1 , SQSTM1 claim 1 , SOD1 claim 1 , UGT1A6 claim 1 , NOS2 claim 1 , NOS3 claim 1 , and PTGS2.3. The oral formulation of claim 2 , wherein at least one of the plurality of agents substantially reverses an age-related change in expression of at least one of the Nrf2-associated genes.4. The oral formulation of claim 1 , wherein the plurality of agents combine to modulate expression of at least five Nrf2-associated genes.5. The oral formulation of claim 1 , wherein at least one of the plurality of agents upregulates a gene encoding intrinsic antioxidants.6. The oral formulation of claim 1 , wherein at least one of the plurality of agents upregulates a gene encoding cellular detoxifiers.7. The oral formulation of claim 1 , wherein at least one of the plurality of agents stimulates autophagy in a tissue of the subject.8. The oral formulation of claim 1 , wherein the plurality of agents include at least two ...

Подробнее
21-03-2013 дата публикации

BATHING COMPOSITION AND METHOD FOR PREPARING SAME

Номер: US20130071376A1
Автор: Lee Dong-Joo
Принадлежит:

The present invention relates to a composition for bath additives characterized in that the composition is obtained by a process comprising subjecting herbal materials comprising 10˜25% by weight of , 10˜20% by weight of , 5˜15% by weight of , 1˜20% by weight of , 1˜15% by weight of , 1˜15% by weight of , 1˜15% by weight of -, 1˜10% by weight of and 1˜10% by weight of , based on the total dry weight of the above herb materials, to liquid phase fermentation with which is anaerobic, to obtain a culture, separating sludge from the resulting culture, drying, sterilizing and pulverizing the culture to give a pulverized sludge, and a process for preparing the same. 1Zizania latifolia,Artemisia capillaries,Houttuynia cordata,Saururus chinensis,Leonurus sibiricus,Angelica gigas,Coix lachrymajobi,Plantago asiaticaRhododendron brachycarpumBacillus subtilis. A composition for bath additives obtained by subjecting medicinal herb materials comprising 10˜25% by weight of 10˜20% by weight of 5˜15% by weight of 1˜20% by weight of 1˜15% by weight of 1˜15% by weight of 1˜15% by weight of -1˜10% by weight of and 1˜10% by weight of , based on the total dry weight of the above herb materials , to liquid phase fermentation with which is anaerobic , to obtain a culture , separating sludge from the resulting culture , drying , sterilizing and pulverizing the culture to give a pulverized sludge.2. The composition for bath additives as claimed in wherein the liquid phase fermentation is performed at a temperature of 30˜40° C. for 50˜100 days.3Achillea sibirica,Rumex crispus, andLithospermum erythrorhizon.. The composition for bath additives as claimed in wherein the above medicinal herb materials further comprise 1˜10% by weight of Saliconia herbacea claim 1 , 7˜17% by weight of 5˜15% by weight of 1˜10% by weight of4. A composition for bath additives characterized in that the composition is obtained by a process comprising:{'i': Zizania latifolia,', 'Artemisia capillaries,', 'Houttuynia ...

Подробнее
04-04-2013 дата публикации

PHARMACEUTICAL COMPOSITION

Номер: US20130084342A1
Автор: NAKAMORI Toshio
Принадлежит:

A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. 1. A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising:1.5 parts by weight powdered fennel;2.0 parts by weight powdered rhubarb;1.0 part by weight powdered glycyrrhiza;2.0 parts by weight powdered phellodendron bark;1.0 part by weight powdered zedoary;1.5 parts by weight powdered picrasma wood;1.0 part by weight powdered matricaria chamomilla;1.5 parts by weight powdered geranium herb;1.0 part by weight powdered ginseng;1.5 parts by weight powdered citrus unshiu peel;1.0 part by weight powdered scutellaria root;1.0 part by weight powdered magnolia bark;2.0 parts by weight powdered oyster shell;1.0 part by weight powdered cyperus rhizome;2.0 parts by weight powdered platycodon root;2.0 parts by weight powdered melia azedarach;1.0 part by weight powdered enidium rhizome;2.0 parts by weight sodium bicarbonate; and4.0 parts ...

Подробнее
04-04-2013 дата публикации

COMPOSITIONS COMPRISING NON-ACIDIC BOSWELLIA OIL FRACTION AS A BIO-ENHANCER FOR ENHANCING BIOAVAILABILITY OF BIOLOGICAL AGENTS

Номер: US20130084348A1
Принадлежит: LAILA NUTRACEUTICALS

The invention relates to a non-acidic low polar gum resin extract fraction (BLPRE) in combination with biological agents for enhancing the bioavailability of the biological agents. The invention also provides composition(s) comprising a low polar gum resin extract (BLPRE) in combination with a biological agent for increasing the bioavailability of biological agent. 1BoswelliaBoswellia. A bio-enhancing agent derived from a gum resin of a species for enhancing the bioavailability of biological agents , said bio-enhancing agent comprising a low polar gum resin extract (BLPRE) derived from said gum resin.2BoswelliaBoswellia. A composition comprising a bio-enhancing agent derived from a gum resin of a species , said bio-enhancing agent comprising a low polar gum resin extract (BLPRE) derived from said gum resin , said composition further comprising a biological agent;wherein said composition contains said bio-enhancing agent in an amount which is effective for enhancing the bioavailability of said biological agent.3BoswelliaBoswellia serrata, Boswellia carterii, Boswellia papyrifera,. The composition according to claim 2 , wherein said species is selected from the group consisting of and mixtures thereof.4. The composition according to claim 2 , wherein said composition contains said bio-enhancing agent in an amount which is effective for enhancing the bioavailability of said biological agent in a warm blooded animal in need thereof.5. The bio-enhancing composition according to claim 4 , wherein said biological agent is at least one agent selected from the group consisting of a biologically active ingredient claim 4 , an herbal ingredients claim 4 , a dietary supplement claim 4 , a nutrient claim 4 , an antioxidant claim 4 , a vitamin claim 4 , a mineral claim 4 , an amino acid claim 4 , an oil claim 4 , and mixtures thereof.6. The bio-enhancing composition according to claim 4 , wherein the said biological agent comprises one or more ingredients selected from the group ...

Подробнее
04-04-2013 дата публикации

Process of preparing burdock composite micron essence

Номер: US20130084380A1
Принадлежит: DONG YUAN BIOTECH PHARMACEUTICAL CO Ltd

A process of preparing a burdock composite micron essence at least includes the following. Dissolved and heated phospholipid is added to a vegetable oil extract and then stirred. After stirring, the above mixture is pour into a heated glycerol and then further stirred and a burdock extract aqueous solution is added. The aforementioned mixed solution is stirred at high speed, the emulsion-homogenized solution is subject to high-pressure homogenization, and a filtration membrane is used to filter the homogenized solution obtained to get a purple transparent burdock concentrate. The burdock concentrate is used to prepare the formulation of nano-micro emulsion which is easily absorbed by human body and thus grants improved health benefits.

Подробнее
18-04-2013 дата публикации

Method And Composition For Improving Skin Barrier Function

Номер: US20130095046A1
Принадлежит:

The invention relates to a method for improving skin lipid barrier function by applying to the skin a composition comprising effective amounts of a protease inhibitor and a cell differentiation enhancer. The composition is useful in promoting skin lipid barrier repair and maintaining the integrity of the lipid barrier. In this regard, the compositions can be used in the treatment and prevention of dry skin, and associated chrono/proto-aging conditions, in the treatment and prevention of irritation on the skin, in the treatment and prevention of UV-related damage to the skin, and in the enhancement of the retention of self-tanning. 1Boswellia. A method for improving skin lipid barrier function comprising applying to the skin a composition comprising from 0.001 to 10% of at least one protease inhibitor which is extract , and from 0.001 to 10% of at least one cell differentiation enhancer which is forskolin.2Boswellia. The method of wherein the extract and the forskolin stimulate the repair of a damaged lipid barrier.3. The method of wherein the composition is applied from 1-2 times per day.4. The method of wherein the composition is applied to skin from 1-2 times per day for 1-3 months.5. The method of wherein the composition further comprises at least one cholesterol.6. The method of wherein the composition contains a mixture of at least one fatty acid claim 1 , at least one ceramide claim 1 , and at least one sterol.7. The method of wherein the composition further comprises a C12-C20 fatty acid.8. The method of containing about 0.05 to 10% of each of cholesterol sulfate claim 1 , fatty acid claim 1 , ceramide claim 1 , and sterol.9. The method of wherein the composition further comprises at least one sunscreen.10. The method of wherein the composition further comprises a self tanning agent.11. The method of wherein the self tanning agent is dihydroxyacetone.12. The method of wherein the composition further comprises cholesterol sulfate.13. The method of wherein the ...

Подробнее
25-04-2013 дата публикации

SUPPLEMENTS AND METHODS OF SUPPLEMENTATION

Номер: US20130101690A1
Автор: TALBOTT Shawn
Принадлежит: DBC, LLC

The present invention provides supplements, combination supplements, methods of treating inflammation, methods of reducing tension, methods of increasing vigor, and methods of increasing metabolic balance. Further, the invention provides methods for supplementing the diet of an individual, and kits for use in supplementation. The supplements, combination supplements, methods and kits of the present invention may be used to achieve an outcome such as increased vigor, decreased tension, improved metabolic balance, and decreased levels of C-reactive protein. 1Citrus sinensisEurycoma longifoliaCamellia sinensisGarcinia mangostanaGarcinia mangostana. A combination supplement comprising extract , extract , extract , L-theanine , pericarp from the fruit of a L. tree , and juice from the fruit of a L. tree.2. The combination supplement of claim 1 , wherein the combination supplement comprises a plurality of dietary supplements.3. The combination supplement of claim 1 , wherein the combination supplement comprises a first dietary supplement and a second dietary supplement.4Citrus sinensisEurycoma longifoliaCamellia sinensisGarcinia mangostanaGarcinia mangostana. The combination supplement of claim 3 , wherein the first dietary supplement comprises extract claim 3 , extract claim 3 , extract claim 3 , and L-theanine claim 3 , and wherein the second dietary supplement comprises pericarp from the fruit of a L. tree claim 3 , and juice from the fruit of a L. tree.5Citrus sinensis. The combination supplement of claim 4 , wherein the first dietary supplement comprises about 23% to about 30% by weight extract.6Eurycoma longifolia. The combination supplement of claim 4 , wherein the first dietary supplement comprises about 6% to about 15% by weight extract.7Camellia sinensis. The combination supplement of claim 4 , wherein the first dietary supplement comprises about 15% to about 23% by weight extract.8. The combination supplement of claim 4 , wherein the first dietary supplement ...

Подробнее
09-05-2013 дата публикации

Indolealkylamino-withasteroid conjugates and method of use

Номер: US20130115316A1
Принадлежит: Natreon Inc

A group of indolealkylamino-withasteroid conjugates, isolated and purified from Withania somnifera , are described. A synthetic method of making an indolealkylamino-withasteroid compound is provided. In vitro acetyl cholinesterase inhibitory activity and methods for treatment of dementia and dementia-related disorders, such as Alzheimer's disease, and anxiety and depressive disorders in mammals are demonstrated with these novel compositions.

Подробнее
16-05-2013 дата публикации

Herbal composition for treating cancer

Номер: US20130122035A1
Автор: Yu-Hwa Peter SHENG
Принадлежит: Individual

An herbal composition and a method for treating cancer, especially for lung cancer, useful for enhancing the quality of life.

Подробнее
23-05-2013 дата публикации

Use of a peptide enhancing the ability of radiation therapy to kill cancer cells

Номер: US20130130991A1
Принадлежит: UNIVERSITÉ DE LAUSANNE

The present invention relates to a peptide consisting essentially of the N2 sequence of the RasGAP protein, a bio logically active fragment thereof, or a variant thereof, which is useful for the preparation of a medicament for the treatment of cancer. Furthermore, it relates to a method of treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of the peptide of the invention.

Подробнее
30-05-2013 дата публикации

PREPARATION FOR WEIGHT LOSS MANAGEMENT

Номер: US20130136814A1
Автор: Chatterji Arun K.
Принадлежит:

extracts together with extracts of one or more of and provide effective weight loss management when administered to a patient desiring weight loss management. Administration of the foregoing also reduces the leptin-to-adiponectin ratio in the patient's blood serum. 1Gymnema sylvestreBoswellia serrataTinospora cordifoliaCommiphora mukul. An oral composition comprising solid , ethanolic extract from leaves containing about 25 to about 55 weight percent gymnemic acid and an enhancer which is a member of the group consisting of a solid , ethanolic extract from gum containing at least 70 weight percent boswellic acids , a solid ethanolic extract from the stems of , a solid ethanolic extract from gum , and mixtures thereof.2Boswellia serrataGymnema sylvestre. The oral composition in accordance with wherein the solid claim 1 , ethanolic extract from gum is present in an amount of at least 3 percent by weight claim 1 , based on the weight of the solid claim 1 , ethanolic extract from leaves.3Tinospora cordifolia.. The oral composition in accordance with wherein said enhancer is a solid ethanolic extract from the stems of4Commiphora mukul. The oral composition in accordance with wherein said enhancer is a solid claim 2 , ethanolic extract from gum.5Gymnema sylvestreBoswellia serrataTinospora cordifoliaCommiphora mukul. The oral composition of comprising said extract claim 1 , said extract and at least one of said extract and said extract.6. A method for reducing leptin-to-adiponectin ratio in serum of a patient which comprises administering to the patient the composition of .7. A method for reducing leptin-to-adiponectin ratio in serum of a patient which comprises administering to the patient the composition of .8. A method for reducing leptin-to-adiponectin ratio in serum of a patient which comprises administering to the patient the composition of .9. A method for reducing leptin-to-adiponectin ratio in serum of a patient which comprises administering to the patient the ...

Подробнее
13-06-2013 дата публикации

COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF

Номер: US20130149398A1
Принадлежит: HAUS BIOCEUTICALS, INC.

Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient. 1. A composition comprising a mixture of plant extracts , wherein the mixture comprises:a) at least one Group I plant extract and at least one Group II plant extract, wherein the at least one Group I plant extract and the at least one Group II plant extract are different;b) at least one Group I plant extract and at least one Group III plant extract, wherein the at least one Group I plant extract and the at least one Group III plant extract are different;c) at least one Group I plant extract and at least one Group IV plant extracts, wherein the at least one Group I plant extract and the at least one Group IV plant extract are different;d) at least one Group II plant extract and at least one Group III plant extracts, wherein the at least one Group II plant extract and the at least one Group III plant extract are different;e) at least one Group II plant extract and at least one Group IV plant extract, wherein the at least one Group II plant extract and the at least one Group IV plant extract are different;f) at least one Group III plant extract and at least one Group IV plant extract, wherein the at least one Group III plant extract and the at least one Group IV plant extract are different;g) at least one Group I plant extract, at least one Group II plant extract, and at least one Group III plant extract, wherein the at least one Group I plant extract, the at least one Group II plant extract, and the at least one Group III plant extract are different;h) at least one Group I plant extract, at least one Group II plant extract, and at least one Group IV plant extract, wherein the at least one Group I plant extract, the at least one Group II plant extract, and the at least one Group IV plant extract are different;i) at least one Group I plant extract, at ...

Подробнее
20-06-2013 дата публикации

PHYTONUTRIENT COMPOSITIONS AND METHODS TO PROTECT AGAINST RADICAL MEDIATED CELLULAR AND DNA DAMAGE

Номер: US20130156870A1
Принадлежит: Metaproteomics, LLC

Phytonutrient based compositions and methods of using the same for preventing, reducing, or treating genetic damage induced by environmental toxins are disclosed. 1Acacia nilotica. A phytonutrient composition for preventing , reducing , or treating genetic damage induced by environmental agents , wherein said composition comprises therapeutically effective amounts of two or more compounds selected from the group consisting of extract , artichoke extract , blueberry extract , catechins , chlorogenic acid , cinnamon , ellagic acid , grape seed extract , hesperidin , Momodica extract , prune extract , rosemary extract , and watercress extract and said composition is in a dosage form suitable for oral administration.2. The composition according to claim 1 , wherein said composition provides per dosage form:{'i': 'Acacia nilotica', 'a. from 0.5 mg to 10 mg of extract;'}b. from 0.5 mg to 10 mg of artichoke extract;c. from 1 mg to 25 mg of blueberry extract;d. from 2.5 mg to 25 mg of catechins;e. from 25 mg to 75 mg of chlorogenic acid;f. from 0.5 mg to 10 mg of cinnamon;g. from 10 mg to 100 mg of ellagic acid;h. from 2.5 mg to 50 mg of grape seed extract;i. from 15 mg to 120 mg of hesperidin;j. from 0.5 mg to 10 mg of Momodica extract;k. from 0.5 mg to 10 mg of prune extract;l. from 0.5 mg to 10 mg of rosemary extract; andm. from 0.5 mg to 10 mg of watercress extract.3Acacia nilotica. A method for preventing claim 1 , reducing claim 1 , or treating genetic damage induced by environmental agents claim 1 , wherein said method comprises administering a composition comprising therapeutically effective amounts of two or more compounds selected from the group consisting of extract claim 1 , artichoke extract claim 1 , blueberry extract claim 1 , catechins claim 1 , chlorogenic acid claim 1 , cinnamon claim 1 , ellagic acid claim 1 , grape seed extract claim 1 , hesperidin claim 1 , Momodica extract claim 1 , prune extract claim 1 , rosemary extract claim 1 , and watercress ...

Подробнее
04-07-2013 дата публикации

COMPOSITION FOR PROMOTING MEMORY AND LEARNING ABILITY

Номер: US20130171278A1
Принадлежит: KOREA FOOD RESEARCH INSTITUTE

The present invention relates to a composition for promoting memory or learning ability and to a composition for preventing and treating cognitive impairment, which comprise one, two or more plant extracts selected from the group consisting of extract, extract and extract. The present invention has the effect of inhibiting neural cell damage, especially, neural cells of the basal part of the cerebrum by inhibiting acetylcholinesterase activity and through antioxidative activity (for example, inhibiting the generation of oxidative reactive species) and affinity for an NMDA receptor. The compositions of the present invention may have the effect of not only promoting memory or learning ability by protecting neural cells and preventing damage to neural cells but also of preventing and treating diseases caused by cognitive impairment. In addition, according to the present invention, extract is provided as basic substance for pharmaceuticals or food which has efficacy in promoting memory or learning ability or efficacy for preventing and treating cognitive impairment. 19-. (canceled)10Artemisia apiaceaeIllicium verumLepidium apefalum.. A method for enhancing memory and learning ability , comprising administering to a subject in need thereof a composition comprising a plant extract as an active ingredient; wherein the plant extract is one or more selected from the group consisting of an extract of , an extract of and an extract of11Artemisia apiaceaeIllicium verumLepidium apefalum.. A method for preventing or treating cognitive disorders , comprising administering to a subject in need thereof a composition comprising a plant extract as an active ingredient; wherein the plant extract is one or more selected from the group consisting of an extract of , an extract of and an extract of12. The method according to claim 10 , wherein the composition inhibits an activity of acetylcholinesterase.13. The method according to claim 10 , wherein the composition has an antioxidant ...

Подробнее
11-07-2013 дата публикации

EXTRACT OF AERIAL PARTS OF MACA RICH IN POLYPHENOLS AND COMPOSITION COMPRISING SAME

Номер: US20130177513A1
Принадлежит: LABORATOIRES EXPANSCIENCE

The invention relates to an extract of aerial parts of Maca rich in polyphenols, and also to a composition comprising such an extract and, where appropriate, a suitable excipient. The invention also relates to a process for extracting an extract of aerial parts of Maca rich in polyphenols, and also to the extract that can be obtained by means of said process. The invention also relates to such a composition or such an extract for use thereof in preventing or treating disorders or pathological conditions of the skin, the mucous membranes or the superficial body growths and/or for use thereof in preventing and/or treating vascular disorders. Finally, the invention relates to a cosmetic care process for the skin, the superficial body growths or the mucous membranes, with a view to improving the condition thereof or the appearance thereof, which comprises the administration of such a composition or of such an extract. 1. Extract of aerial parts of Maca containing at least 1% , advantageously at least 3% , more advantageously at least 5% by weight of polyphenols , expressed in gallic acid equivalents , with respect to the weight of the dry extract , said polyphenols being advantageously flavonoids , typically having a flavonoid content greater than 0.2% , advantageously greater than 0.5% , more advantageously greater than 1% and even more advantageously greater than 2% , expressed in rutin equivalents , with respect to the total weight of the dry extract.2. Extract according to claim 1 , characterised in that the flavonoids contain quercetin claim 1 , kaempferol claim 1 , derivatives thereof or mixtures thereof claim 1 , advantageously at a concentration of at least 30% claim 1 , typically at least 50% claim 1 , by weight claim 1 , expressed in gallic acid equivalents claim 1 , with respect to the total weight of the flavonoids.3. Extract according to or claim 1 , characterised in that aerial parts are Maca leaves.4. Extract according to any of the above claims claim 1 , ...

Подробнее
11-07-2013 дата публикации

Natural Means of Augmenting Endogenous Stem Cell Numbers

Номер: US20130177543A1
Принадлежит: CREATIVE MEDICAL HEALTH INC.

Disclosed are compositions of matter, uses, and therapeutic interventions directed towards modulation of stem cell activity in a mammal. In particular the invention provides compositions whose end result modulates health, wellbeing, longevity and function of organ systems. Within the scope of the invention are biologically active extracts, components thereof, and compositions (such as cosmetic or pharmaceutical preparations) made comprising such. 1Garcinia Indica.. A method of augmenting stem cell numbers in circulation comprising administering to a mammal a composition comprising of one or more ingredients selected from the group consisting of: a) Ashwagandha; b) Milk Thistle; c) Vitamin D3; d) Fucoidan; and e)2Garcinia Indica.. The method of claim 1 , wherein said composition comprises approximately 50-300 mg Ashwagandha claim 1 , 500-2000 IU Vitamin D3 claim 1 , 100-1000 mg Fucoidan claim 1 , and 50-500 mg of3Garcinia Indica.. The method of claim 1 , wherein said composition comprises approximately 100 mg Ashwagandha claim 1 , 1000 IU Vitamin D3 claim 1 , 500 mg Fucoidan claim 1 , and 250 mg of4. The method of claim 1 , wherein said composition is administered between 1 time per day claim 1 , to 10 times per day.5. The method of claim 1 , wherein said composition is administered approximately 2 times per day.6. The method of claim 1 , wherein said composition is administered to a patient with low circulating endothelial progenitor cells and dose of said composition is administered according to desire to increase circulating endothelial progenitor cells.7. The method of claim 6 , wherein said endothelial progenitor cells are cells capable of forming endothelial colonies in vitro.8. The method of claim 6 , wherein said endothelial progenitor cells express a marker selected from the group consisting of: a) CD34; b) CD133; c) KDR-1; d) stem cell antigen; e) CD146; f) CD31; g) Tie-2; h) CD144; and i) VEGFR3.9. The method of claim 6 , wherein said endothelial ...

Подробнее
08-08-2013 дата публикации

Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof

Номер: US20130202570A1
Автор: Omar M. Amin
Принадлежит: Individual

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Подробнее
08-08-2013 дата публикации

Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof

Номер: US20130202722A1
Автор: Omar M. Amin
Принадлежит: Individual

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Подробнее
29-08-2013 дата публикации

COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS INCLUDING GALENICAL EXTRACT OR LACTOBACILLUS FERMENTATION THEREOF

Номер: US20130224181A1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a pharmaceutical composition and health supplement for preventing or treating atopic dermatitis, the composition and supplement having as active ingredients extract of a galenical mixture including sophora root, licorice, lonicer aflower, Korean angelica root, Korean aralia root, saussurea root, seselos radix, zizyphus spinosi, Houttuynia cordata, forsythia fruit, lappa fruit, Epimedium koreanum Nakai, ginseng, lithospermum, oleoresin, cnidium, scorophulariae radix, and reynoutria, or lactobacillus fermentation of the galenical extract prepared by inoculating lactobacillus to the galenical extract and fermenting same. The galenical extract or the galenical extract fermentation of the present invention achieves reduced scratching, decreases clinical features of atopic symptoms such as erythema, itchiness and dry skin, edema and hematoma, erosion, and lichenification, and reduces IgE concentration in blood, which is related to exogenous atopic dermatitis, in laboratory animal models of atopic dermatitis, and is thereby, useful for preventing or treating atopic dermatitis. 1. A herb extract prepared by extracting a herb mixture comprising Sophora flavescens , Licorice (Glycyrrhiza uralensis) , Lonicera jabonica , Angelica gigas , Aralia continentalis , Saussurea lappa , Bangpoong (Saposhnikovia divaricata) , Zizyphus jujuba , Houttuynia cordata , Forsythia koreana , Arctii Fructus , Epimedium koreanum , Ginseng , Lithospermi Radix , Sanguisorbae officinalis , Cnidium officinale , Scrophularia buergeriana , and Reynoutria elliptica by using water or an organic solvent.2. The herb extract according to claim 1 , wherein the herb extract is extracted by hot-water extraction from the herb mixture comprising 10 weight parts of Sophora flavescens claim 1 , 2˜8 weight parts of Licorice (Glycyrrhiza uralensis) claim 1 , 2˜8 weight parts of Lonicera jabonica claim 1 , 2˜8 weight parts of Angelica gigas claim 1 , 2˜8 weight parts of Aralia ...

Подробнее
19-09-2013 дата публикации

Use of a Traditional Chinese Medicine Composition for Manufacturing a Health Food or Medicament for Preventing and Alleviating Physical Fatigue

Номер: US20130243748A1
Принадлежит: JIANGZHONG PHARMACEUTICAL CO., LTD.

The present invention provides a use of traditional Chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue. The composition consists of 5-90 parts by weight of Radix Panacis Quinquefolii, 5-160 parts by weight of 1-90 parts by weight of fermented powder and/or 1-120 parts by weight of , and these ingredients are made from Chinese crude drugs or from Chinese crude drug extracts in amounts equivalent to those of the Chinese crude drugs. The composition may further contain 5-90 parts by weight of Flos Rosae Rugosae. The present invention also relates to the use of said composition in the manufacture of prophylactic or therapeutic health foods or medicaments for reducing blood lipids, for resisting oxidation, and for enhancing anoxia endurance. The medicine composition of the present invention can be prepared into any conventional dosage forms by adding any pharmaceutically acceptable auxiliary agents. 1GanodermaCordyceps sinensis. A method of resisting oxidation or enhancing anoxia endurance comprising the step of administering a composition to a subject , wherein the composition comprises raw materials of 10-50 parts by weight of Radix Panacis Quinquefolii , 10-50 parts by weight of , and 10-50 parts by weight of fermented powder , or water extracts of said raw materials , as active ingredients.2. The method of claim 1 , characterized in that said raw materials further include 10-40 parts by weight of Flos Rosae Rugosae claim 1 , or a water extract of 10-40 parts by weight of Flos Rosae Rugosae.3GanodermaCordyceps sinensis. The method of claim 1 , characterized in that the raw materials are 30 parts of Radix Panacis Quinquefolii claim 1 , 40 parts of claim 1 , and 20 parts of fermented powder.4. The method of claim 3 , characterized in that said raw materials further include 30 parts by weight of Flos Rosae Rugosae claim 3 , or a water extract of 30 parts by weight of Flos Rosae Rugosae. ...

Подробнее
10-10-2013 дата публикации

COMPOSITIONS AND METHODS FOR TREATMENT AND MANAGEMENT OF PAIN

Номер: US20130266673A1
Автор: Ghorbani Reza
Принадлежит:

Disclosed herein are compositions and methods for the treatment and management of pain in a subject comprising or consisting of topically or orally administering a therapeutic effective amount of a composition. The composition is made up of minute amounts of herbal extracts and compound mixtures to a subject. The composition includes turmeric extract, extract, ginger extract, holy basil extract, rosemary extract, white willow extract and alpha lipolic acid each in minute amounts. 1Boswellia. An herbal composition for the management of pain comprising turmeric extract , extract , ginger extract , holy basil extract , rosemary extract , willow bark extract and alpha lipolic acid and wherein each of said extracts and said alpha lipolic acid include an amount of active ingredients of between 0.00015% by wgt. and 0.01% by wgt.2Boswellia. The herbal composition for the management of pain according to claim 1 , which includes turmeric extract in an amount of between 0.00864% by wgt. and 0.01966% by wgt. claim 1 , extract in an amount of between 0.0063% by wgt. and 0.0077% by wgt. claim 1 , ginger extract in an amount of between 0.00045% by wgt. and 0.00055% by wgt. claim 1 , holy basil extract in an amount of between 0.00018% by wgt. and 0.00022% by wgt. claim 1 , rosemary extract in an amount of between 0.00054% by wgt. and 0.00066% by wgt. claim 1 , willow bark extract in an amount between 0.00135% by wgt. and 0.00165% by wgt. and alpha lipolic acid in an amount between 0.009% by wgt. and 0.011% by wgt.3Boswellia. The herbal composition for the management of pain according to claim 2 , which includes turmeric extract in an amount of about 0.0096% by wgt. claim 2 , extract in an amount of about 0.007% by wgt. claim 2 , ginger extract in an amount of about 0.0005% by wgt. claim 2 , holy basil extract in an amount of about 0.0002% by wgt. claim 2 , rosemary extract in an amount of about 0.0006% by wgt. claim 2 , willow bark extract in an amount of about 0.0015% by wgt. and ...

Подробнее
31-10-2013 дата публикации

Composition and method to alleviate joint pain

Номер: US20130287756A1
Принадлежит: US Nutraceuticals LLC

Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.

Подробнее
31-10-2013 дата публикации

PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING A MEDICATION FOR PROMOTING WOUND HEALING

Номер: US20130287873A1

The disclosure provides a pharmaceutical composition for promoting wound healing, including an effective amount of a plant or an plant as an active ingredient for promoting wound healing; and a pharmaceutically acceptable carrier or medium, wherein the plant is Nakai, and the plant is Fort. 1. A pharmaceutical composition , comprising:{'i': 'Sambucus', 'an effective amount of a plant as an active ingredient for promoting wound healing; and'}a pharmaceutically acceptable carrier or medium.2SambucusSambucusSambucusSambucusSambucusSambucusSambucus. The pharmaceutical composition as claimed in claim 1 , wherein a part of the plant used in the pharmaceutical composition comprises a whole plant of the plant claim 1 , a root of the plant claim 1 , a stem of the plant claim 1 , a leaf of the plant claim 1 , a flower of the plant and/or a fruit of the plant.3SambucusSambucus. The pharmaceutical composition as claimed in claim 1 , wherein the plant is subjected to an extraction process to yield an extract of the plant.4SambucusSambucusSambucusSambucusSambucusSambucusSambucus. The pharmaceutical composition as claimed in claim 3 , wherein a part of the plant used in the pharmaceutical composition comprises a whole plant of the plant claim 3 , a root of the plant claim 3 , a stem of the plant claim 3 , a leaf of the plant claim 3 , a flower of the plant and/or a fruit of the plant.5SambucusSambucus formosanaSambucus japonicaSambucus nigraSambucus williamsiiSambucus williamsiimiquelii. The pharmaceutical composition as claimed in claim 1 , wherein the plant comprises Nakai claim 1 , Thunb. claim 1 , L. claim 1 , Hance or Hance var. (Nakai) Y. C. Tang.6SambucusSambucus formosana. The pharmaceutical composition as claimed in claim 1 , wherein the plant is Nakai.7Sambucus formosanaSambucus formosanaSambucus formosanaSambucus formosanaSambucus formosanaSambucus formosanaSambucus formosana. The pharmaceutical composition as claimed in claim 6 , wherein a part of the Nakai used in the ...

Подробнее
07-11-2013 дата публикации

FORMULATIONS COMPRISING SAPONINS AND USES THEREOF

Номер: US20130295204A1
Автор: Silberstein Tova
Принадлежит: Y&B Mother's Choice Ltd.

Provided is a formulation including various natural extracts for a variety of human applications. 149.-. (canceled)50Lonicera, Populus, SalixWasabia. A composition comprising at least one saponin material and an extract from at least one plant species of a genus selected from the group consisting of , and or a mixture thereof.51. The composition according to claim 50 , wherein the saponin material is selected from the group consisting of at least one naturally obtained saponin compound claim 50 , at least one saponin-containing extract and a mixture thereof.52. The composition according to claim 50 , wherein the saponin material is obtained by extraction from a plant source claim 50 , said extraction process being carried out by water claim 50 , alcohol or a water/alcohol solution.53. The composition according to claim 52 , wherein the water/alcohol solution has a water:alcohol ratio selected from the group consisting of a ratio of between 80:20 and 20:80 claim 52 , a ratio of between 60:40 and 40:60 claim 52 , a ratio of between 70:30 and 30:70 and 50:50.54Camellia sinensis, Camellia oleifera, Saponaria officinalisSapindus mukorossi. The composition according to claim 50 , wherein the saponin material is an extract selected from the group consisting of claim 50 , or or a mixture thereof.55. The composition according to claim 50 , wherein the saponin material is extracted from a plant source following a method comprising:1. treating the plant source in a water:alcohol solution having a water:alcohol ratio of between 40:60 and 60:40 for a period of time and under conditions permitting extraction of the saponin material from said plant source into said solution;2. optionally, evaporating the saponin-containing solution to obtain a saponin-containing solid material; and3. optionally, purifying said saponin-containing solid material.56. The composition according to claim 55 , wherein the water:alcohol ratio is 50:50.57Camellia oleiferaSapindus mukorossi.. The ...

Подробнее
14-11-2013 дата публикации

Pharmaceutical Composition for Relieving Fatigue and Preparation Method Thereof

Номер: US20130302310A1
Принадлежит:

Pharmaceutical composition for relieving fatigue and preparation method thereof. A pharmaceutical composition for relieving fatigue and preparation method thereof are provided. The pharmaceutical composition is prepared by mixing ethanol extract of ginseng, ethanol extract of , ethanol extract of , ethanol extract of yam, ethanol extract of , ethanol extract of dodder, aqueous extract of wolfberry and a fermentation conversion solution of fruits and vegetables. 19-. (canceled)10. A method for preparing a pharmaceutical composition for relieving fatigue , comprising:mixing the following eight substances for obtaining a mixture, wherein the mixture is the pharmaceutical composition for relieving the fatigue, wherein the eight substances comprises:{'i': astragalus', 'epimedium', 'polygonatum, 'A. ethanol extract of ginseng; B. ethanol extract of ; C. ethanol extract of ; D. ethanol extract of yam; E. ethanol extract of ; F. ethanol extract of dodder; G. aqueous extract of wolfberry; H. a fermentation conversion solution of fruits and vegetables;'}wherein a method for preparing the A substance comprises: processing reflux extraction on the ginseng with an aqueous solution of ethanol for obtaining the extract, wherein the extract is the ethanol extract of the ginseng;{'i': astragalus', 'astragalus;, 'wherein a method for preparing the B substance comprises: processing the reflux extraction on the with the aqueous solution of the ethanol for obtaining the extract, wherein the extract is the ethanol extract of the'}{'i': epimedium', 'epimedium;, 'wherein a method for preparing the C substance comprises: processing the reflux extraction on the with the aqueous solution of the ethanol for obtaining the extract, wherein the extract is the ethanol extract of the'}wherein a method for preparing the D substance comprises: processing the reflux extraction on the yam with the aqueous solution of the ethanol for obtaining the extract, wherein the extract is the ethanol extract of ...

Подробнее
21-11-2013 дата публикации

Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease

Номер: US20130310454A1

Disclosed is a composition for treating or preventing gastroesophageal reflux disease, which includes an organic solvent extract of Lonicerae Flos Thunberg. A fraction of the disclosed extract can be very effectively used for treating, preventing, or improving gastroesophageal reflux disease without side effects.

Подробнее
28-11-2013 дата публикации

Oral Composition for the Treatment of Acne

Номер: US20130316017A1
Автор: Hynes Michael
Принадлежит:

Provided is a composition that is useful for treating acne, and which has been found to reduce and/or eliminate acne outbreaks or reduce the severity thereof. The composition includes mangosteen and curcumin. At least a portion of the mangosteen and curcumin can be provided in the form of extracts thereof. The composition can optionally include other components such as guggul, guggul extracts, thyme, thyme extracts, piperine, vitamin B5, vitamin B6, zinc, beta glucans, and green tea extracts. The composition can be provided as an oral administration unit such as a pill or capsule. Also provided is a method of treating acne by ingesting an effective amount of the composition described herein. 1. A composition for the treatment of acne , comprising mangosteen and curcumin.2. The composition of claim 1 , wherein at least a portion of the mangosteen is provided as a mangosteen extract and at least a portion of the curcumin is provided as a curcumin extract.3. The composition of claim 1 , wherein the composition comprises between 10 and 70% mangosteen and between 30 and 55% mangosteen based on the total weight of the composition.4. The composition of claim 1 , wherein at least a portion of the curcumin is provided in a highly bioavailable form.5. The composition of claim 1 , wherein at least a portion of the curcumin is provided as a curcuminoid complex.6. The composition of claim 1 , further comprising one or more of guggul claim 1 , guggul extracts claim 1 , thyme claim 1 , thyme extracts claim 1 , piperine claim 1 , vitamin B5 claim 1 , vitamin B6 claim 1 , zinc claim 1 , beta glucans claim 1 , and green tea extracts.7. The composition of claim 2 , further comprising piperine.8. The composition of claim 2 , further comprising guggul or extracts thereof.9. A method of treating acne claim 2 , comprising:ingesting, on a periodic basis and over a time sufficient to treat the acne, an effective amount of a composition comprising mangosteen and curcumin.10. The method of ...

Подробнее
12-12-2013 дата публикации

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

Номер: US20130330426A1
Принадлежит: MARY KAY INC.

Disclosed are compositions that include extracts from a and 1. A topical skin composition comprising:{'i': 'Lonicera maackii', '(a) an effective amount of an extract from the plant of , wherein said extract is capable of reducing TNF-α or elastase activity in skin; and'}{'i': 'Polygonum', '(b) an effective amount of an extract from the plant of hydropiper, wherein said extract is capable of reducing oxidation in skin or reducing TNF-α or elastase activity in skin.'}2. The topical skin composition of claim 1 , wherein the composition is a lotion claim 1 , cream claim 1 , or gel.3. The topical skin composition of claim 1 , wherein the composition is an emulsion.4Lonicera maackiiPolygonum hydropiper. The topical skin composition of claim 1 , wherein the and extracts are aqueous extracts.5Lonicera maackiiPolygonum hydropiper. The topical skin composition of claim 1 , wherein the composition comprises from 0.01% to 20% by weight of extract and 0.01% to 20% by weight of extract.6. The topical skin composition of claim 1 , wherein the composition further comprises water.7. The topical skin composition of claim 7 , wherein the composition further comprises an emulsifier. This application is a divisional of U.S. application Ser. No. 13/323,402, filed Dec. 12, 2011, which is a continuation of U.S. Pat. No. 8,273,387, filed Aug. 26, 2010, which claims the benefit of U.S. Provisional Application No. 61/237,087, filed Aug. 26, 2009. The contents of the referenced applications are incorporated into the present application by reference.A. Field of the InventionThe present invention relates generally to compositions that include one or any combination of plant extracts selected from the group consisting of: ; and ; and any combination of extracts thereof. In particular aspects, the compositions include an extract selected from the group consisting of: extract; extract; extract; and extract; and any combination thereof. The compositions can be formulated as topical skin compositions ...

Подробнее
12-12-2013 дата публикации

METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS

Номер: US20130330428A1
Автор: Geng Lisa
Принадлежит:

Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed. 154-. (canceled)55gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalisterminalis chebula.. A method for treating apraxia , autism , speech impairments , traumatic brain injury , seizure disorders , epilepsy , global delays , or ADHD , comprising administering to a patient in need thereof a nutrient composition that ameliorates one or more symptoms of apraxia , autism , speech impairments , traumatic brain injury , seizure disorders , epilepsy , global delays , or ADHD , said nutrient composition comprising an effective amount of a mixture or purified mixture thereof comprising three or more botanical extracts selected from the group of botanicals consisting of , and56. A method according to claim 55 , wherein the nutrient composition is in granular or powder form.57. A method according to claim 56 , wherein the nutrient composition is capable of being administered orally.58. A method according to claim 57 , wherein the nutrient composition is combined with a liquid vehicle for oral consumption by the patient.59. A method according to claim 58 , wherein the liquid vehicle comprises water or milk.60gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalisterminalis chebula,. A method according to claim 55 , wherein the nutrient composition comprises a mixture or purified mixture thereof comprising botanical extracts selected from each of claim 55 , and61cinnamomum verumcapsicum annuum.. A method according to claim 60 , wherein the nutrient composition further comprises or62. A method according to claim 55 , wherein the ...

Подробнее
19-12-2013 дата публикации

COMPOSITION FOR PREVENTING OR TREATING HEARING LOSS

Номер: US20130337089A1
Автор: Hong Bin Na, Kang Tong Ho

Disclosed is a pharmaceutical composition for preventing or treating hearing loss, comprising Choisy extract, or the extract of Libschitz var. MAKINO and Choisy. In addition, the present invention provides a food composition for preventing or ameliorating hearing loss, comprising Choisy extract, or the extract of Libschitz var. MAKINO and Choisy. The composition inhibits hearing loss, in particular, acoustic trauma, temporary or permanent hearing loss by effectively inhibiting the threshold shift induced by noise and the likes, and thusit is effective in preventing or treating hearing loss. In addition, it can be administered orally, thereby drug compliance of patients can be enhanced. 1Cuscuta japonicaRehmannia glutinosapurpureaCuscuta japonica. A pharmaceutical composition for preventing or treating hearing loss , comprising Choisy extract , or the extract of Libschitz var. MAKINO and Choisy.2. The pharmaceutical composition according to claim 1 , wherein the hearing loss is noise-induced hearing loss.3Rehmannia glutinosapurpureaCuscuta japonicaRehmannia glutinosapurpureaCuscuta japonica. The pharmaceutical composition according to claim 1 , wherein the extract of Libschitz var. MAKINO and Choisy comprises 1:1.8 to 1:9 ratio of Libschitz var. MAKINO to Choisy.4Cuscuta japonicaRehmannia glutinosapurpureaCuscuta japonica. The pharmaceutical composition according to claim 1 , wherein the extract is obtained by extract process comprising the extraction step of Choisy claim 1 , or Libschitz var. MAKINO and Choisy with the extraction solvent selected from the group consisting of water claim 1 , C˜Calcohol claim 1 , and the mixed solvent of water and C˜Calcohol.5Rehmannia glutinosapurpureaRehmannia glutinosapurpureaRehmannia glutinosapurpureaRehmannia glutinosapurpureaCuscuta japonicaCuscuta chinensisCuscuta pentagonaCuscuta japonicaCuscuta australis. The pharmaceutical composition according to claim 1 , wherein the Libschitz var. MAKINO is at least one selected from the ...

Подробнее
19-12-2013 дата публикации

PLANT EXTRACTS FOR TREATING BURNS AND CHRONIC WOUNDS

Номер: US20130337090A1
Автор: Doron Shirli
Принадлежит: SKIN MATRIX LTD.

The present invention provides compositions and methods for treating burns and chronic wounds, particularly compositions comprising an oil extract or oily suspension of a combination of plant material derived from several plant species for treating burns and chronic sores. 1Harpagophytum procumbensAngelica archangelica. A composition comprising as an active ingredient an oil extract or oily suspension of a combination of ground roots of (Devil's claw) and (Angelica).2Hydrastis canadensis. The composition of claim 1 , wherein the active ingredient further comprises an oil extract or oily suspension of ground roots of (Golden Seal).3Astragalus membranaceousSymphytum officinaleUrtica dioica. The composition of claim 1 , further comprising an oil extract or oily suspension of at least one of ground root of (Astragalus); ground leaves of (Comfrey) ground leaves of (Stinging Nettle) or any combination thereof.4Agrimonia Eupatoria. The Composition of claim 3 , further comprising an oil extract or oily suspension of ground leaves of (Agrimony) and ground blue-green algae.5Harpagophytum procumbensAngelica ArchangelicaAstragalus membranaceousSymphytum officinaleUrtica dioicaAgrimonia Eupatoria. The composition of comprising as an active ingredient an oil extract or oily suspension of a combination of ground plant material comprising roots of (Devil's claw) claim 4 , (Angelica) and (Astragalus); leaves of (Comfrey) claim 4 , (Stinging Nettle) and (Agrimony); and blue-green algae.6Hydrastis Canadensis. The composition of claim 5 , wherein the active ingredient further comprises an oil extract or oily suspension of ground roots of (Golden Seal).7Harpagophytum procumbensAngelica ArchangelicaAstragalus membranaceousSymphytum officinaleUrtica dioicaAgrimonia Eupatoria. The composition of claim 5 , consisting of an oil extract or oily suspension of a combination of ground plant material consisting of roots of (Devil's claw) claim 5 , (Angelica) and (Astragalus); leaves of (Comfrey) ...

Подробнее
19-12-2013 дата публикации

PHYTONUTRIENT COMPOSITIONS AND METHODS OF USE

Номер: US20130337092A1
Принадлежит: Metaproteomics, LLC

Phytonutrient based compositions and methods of using the same for preventing, reducing, or treating genetic damage induced by environmental toxins are disclosed. Additionally, said compositions and methods are used to reduce oxidized low density lipoproteins (OxLDL), myeloperoxidase (MPO), and plasminogen activator inhibitor-1 (PAI-1). 1Acacia niloticaMomodica. Use of a composition for simultaneously reducing serum OxLDL , MPO , and PAI-1 levels in a subject in need thereof , wherein said use comprises administering a composition comprising therapeutically effective amounts of two or more compounds or extracts selected from the group consisting of extract , artichoke extract , blueberry extract , catechins , chlorogenic acid , cinnamon , ellagic acid , grape seed extract , hesperidin , extract , prune extract , rosemary extract , and watercress extract and said composition is in a dosage form suitable for oral administration wherein said dosage form provides:{'i': 'Acacia nilotica', 'a. from 0.5 mg to 10 mg of extract;'}b. from 0.5 mg to 10 mg of artichoke extract;c. from 1 mg to 25 mg of blueberry extract;d. from 2.5 mg to 25 mg of catechins;e. from 25 mg to 75 mg of chlorogenic acid;f. from 0.5 mg to 10 mg of cinnamon;g. from 10 mg to 100 mg of ellagic acid;h. from 2.5 mg to 50 mg of grape seed extract;i. from 15 mg to 120 mg of hesperidin;{'i': 'Momodica', 'j. from 0.5 mg to 10 mg of extract;'}k. from 0.5 mg to 10 mg of prune extract;l. from 0.5 mg to 10 mg of rosemary extract; andm. from 0.5 mg to 10 mg of watercress extract.2Acacia niloticaMomodica. The use according to claim 1 , wherein the composition provides three or more compounds or extracts selected from the group consisting of extract claim 1 , artichoke extract claim 1 , blueberry extract claim 1 , catechins claim 1 , chlorogenic acid claim 1 , cinnamon claim 1 , ellagic acid claim 1 , grape seed extract claim 1 , hesperidin claim 1 , extract claim 1 , prune extract claim 1 , rosemary extract claim 1 ...

Подробнее
19-12-2013 дата публикации

Lipid comprising polyunsaturated fatty acids

Номер: US20130338388A1

The present invention relates to extracted plant lipid, comprising fatty acids in an esterified form.

Подробнее
02-01-2014 дата публикации

COMPOSITIONS AND METHODS FOR MANAGING WEIGHT

Номер: US20140004215A1
Принадлежит:

The present disclosure provides Diels-Alder adducts of chalcone and prenylphenyl moieties capable of modulating the activity of cannabinoid receptors, and to oligomers of flavan-3-ol capable of modulating fat absorption and storage. Such Diels-Alder adducts of chalcone and prenylphenyl moieties or oligomers of flavan-3-ol can optionally be used in combination with other weight management agents, such as anorectic agents, a lipase inhibitors, other cannabinoid receptor modulators, psychotropic agents, insulin sensitizers, stimulants, or satiety agents, as well as to methods of use thereof such as treating or preventing weight gain or obesity, promoting weight loss, appetite suppression, modifying satiety, or the like. 1MorusMagnoliaYerba mate. A composition , comprising a mixture of a extract enriched for one or more Diels-Alder adducts of a chalcone and a prenylphenyl moiety , a extract , and a extract.2MorusMorus albaMagnoliaMagnoliaYerba mateIlex paraguayensis.. The composition according to claim 1 , wherein the extract is from claim 1 , the extract is from officinalis claim 1 , and the extract is from4. The composition of claim 1 , wherein at least two of R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , Rand Rare hydroxyl.5Morus. The composition according to claim 1 , wherein the extract is enriched for Albanin G claim 1 , Kuwanon G claim 1 , Morusin claim 1 , or any combination thereof.6Magnolia. The composition according to claim 1 , wherein the extract is enriched for magnolol claim 1 , honokiol claim 1 , or both.7Yerba mate. The composition according to claim 1 , wherein the extract is enriched for caffeine claim 1 , dicaffeoylquinic acid claim 1 , or both.8. The composition according to claim 1 , wherein the composition further comprises a ...

Подробнее
09-01-2014 дата публикации

PHARMACEUTICAL COMPOSITION CONTAINING ACTIVE VEGETABLE SUBSTANCES

Номер: US20140010900A1
Автор: Spitz Marco
Принадлежит:

The invention relates to a pharmaceutical composition containing active vegetable substances and a mixture made of a polymeric water-soluble and a polymeric water-insoluble matrix forming agent. Said pharmaceutical composition is suitable for the oral administration of active vegetable substances with delayed release. 1. A pharmaceutical composition in solid form for the oral administration of active plant substances with delayed release , comprising a plant preparation containing the pharmacologically efficacious substances and a mixture of a polymeric water-soluble and a polymeric water-insoluble matrix-forming agent.2. The pharmaceutical composition according to claim 1 , containing a plant extract or a combination of plant extracts as plant preparation.3. The pharmaceutical composition according to claim 1 , containing hypericum extract.4. The pharmaceutical composition according to claim 1 , containing Ginkgo biloba extract.5. The pharmaceutical composition according to containing a pore-forming agent.6. The pharmaceutical composition according to containing one or a plurality of polymeric water-soluble matrix-forming agents selected among hydroxypropylmethylcellulose claim 1 , hydroxypropylcellulose claim 1 , poloxamer and polyvinylpyrrolidone.7. The pharmaceutical composition according to containing one or a plurality of polymeric water-insoluble matrix-forming agents selected among ethylcellulose claim 1 , vinylpyrrolidone/vinylacetate copolymer claim 1 , polyvinylpyrrolidone/polyvinylacetate mixture claim 1 , polyacrylic acid copolymer claim 1 , polymers of acrylic acid with polyalkenylether claim 1 , polymethacrylic acid ester copolymer and methacrylic acid ester copolymer.8. The pharmaceutical composition according to containing the plant preparation at a content share of 50%.9. The pharmaceutical composition according to containing the plant preparation at a content share of over 65%.10. The pharmaceutical composition according to in the administration ...

Подробнее
16-01-2014 дата публикации

SILENE CAPENSIS FOR INHIBITING CRAVINGS

Номер: US20140017177A1
Принадлежит:

A composition can include: silene extract; and a carrier having the silene extract. The composition can include an active agent, such as a pharmaceutical or a nutraceutical. The composition can be in a form of a solid, paste, gel, gum, or combination thereof. The carrier can facilitate retention in the mouth, chewing, sucking, holding in the lip next to the gums, or other non-liquid format. A method can provide an alternative to an activity that reduces desire to perform the activity, the method can include: administering to a subject in need thereof the composition having silene. The method can include administering the composition in an effective amount to treat one or more of smoking dependence, tobacco withdrawal symptoms, and tobacco dependence in the subject, wherein the activity is smoking. 1. A composition comprising:silene extract; anda carrier having the silene extract.2. The composition of claim 1 , comprising an active agent.3. The composition of claim 1 , wherein the composition is in a form of a solid claim 1 , paste claim 1 , gel claim 1 , gum claim 1 , or combination thereof.4. A method of providing an alternative to an activity that reduces desire to perform the activity claim 1 , the method comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'administering to a subject in need thereof the composition of .'}5. The method of claim 4 , comprising administering the composition in an effective amount to treat one or more of smoking dependence claim 4 , tobacco withdrawal symptoms claim 4 , and tobacco dependence in the subject claim 4 , wherein the activity is smoking.6. The method of claim 4 , wherein the activity is eating and the composition is administered in an effective amount to reduce desire to eat.7. The method of claim 4 , wherein the activity is alcohol consumption and the composition is administered in an effective amount to reduce desire to consume alcohol.8. The method of claim 4 , wherein the reduced desire is compared to the ...

Подробнее
23-01-2014 дата публикации

Method and Composition for Ameliorating the Effects tor a Subject Exposed to Radiation or Other Sources of Oxidative Stress

Номер: US20140023701A1
Принадлежит:

Radiation-oxidative exposure treatment compositions comprise a mixture of micronutrient multivitamin and trace elements, a mixture of antioxidants and chemopreventative agents, and optionally a mixture of fatty acids. Micronutrient multivitamin and trace elements mixtures include vitamins A, Bp, B1, B2, B3, B5, B6, B7, B9, B12, C, D, E and K; inositol; calcium, iodine, magnesium, zinc, selenium, copper, manganese, chromium, molybdenum, potassium, boron and vanadium. Mixtures of non-essential antioxidants and chemopreventative agents include bioflavins, alpha lipoic acid, N-acetyl-L-cysteine (optionally) lutein, lycopene, astaxanthin, plant sterols, isoflavones, garlic extract, which provides allicin; green tea extract, cruciferous vegetable extract, fruit extracts, coenzyme Q-10, and resveratrol. Fatty acid mixtures include eicosapentaenoic acid and docosahexaenoic acid. 2. The composition of where the mixture of micronutrient multivitamin and trace elements comprises:biotin in an amount of about 0.187 mg;folate in an amount of about 0.25;iodine in an amount of about 0.0187 mg;manganese in an amount of about 1.25 mg;pantothenic acid in an amount of about 12.5 mg;selenium in an amount of about 0.0875 mg;vitamin B1 in an amount of about 1.9 mg;vitamin B12 in an amount of about 0.0075 mg;vitamin B2 in an amount of about 2.1 mg;vitamin B3 in an amount of about 25 mg;vitamin B6 in an amount of about 2.5 mg;vitamin C in an amount of about 75 mg;vitamin D in an amount of about 0.0125 mg;vitamin E in an amount of about 20 mg;vitamin K in an amount of about 0.056 mg;lycopene in an amount of about 1.25 mg;zinc in an amount of about 18.7 mg;alpha lipoic acid in an amount of about 125 mg;astaxanthin in an amount of about 0.31 mg;lutein in an amount of about 6.25 mg;vitamin A in an amount of about 0.938 mg;quercetin in an amount of about 64 mg;glutathione in an amount of about 125 mg; andwhere calcium, chromium, copper, magnesium, molybdenum, inositol and resveratrol are not ...

Подробнее
23-01-2014 дата публикации

METHOD OF EXTRACTING ACTIVE MOLECULES FROM NATURAL RESINS AND USE THEREOF

Номер: US20140023721A1
Принадлежит: RODE PHARMA S.R.L.

The present invention relates to a method of extracting active molecules from natural resins and/or essential oils. In particular, the present invention relates to a method of extracting active molecules selected from the group comprising terpenes, flavonoids, anthocyanins and catechins. Moreover, the present invention relates to an extract, preferably in liquid form, obtained with said method. Finally, the present invention relates to the use of said extract containing the active molecules selected from the group comprising terpenes, flavonoids, anthocyanins and catechins for the preparation of a food composition or supplement or a pharmaceutical composition. 1. A method of extracting active molecules from a vegetable substrate , said method comprising contacting said substrate with an extraction liquid , said extraction liquid comprising:an extraction gas in the gaseous state at a temperature of 23° C. and pressure of 1 atmosphere, andan extraction solvent comprising acetic acid.2. The method according to claim 1 , wherein the active molecules extracted from the vegetable substrate are selected from the group comprising terpenes claim 1 , flavonoids claim 1 , anthocyans and catechins.3. The method according to claim 1 , wherein the vegetable substrate is selected from the group comprising natural resins claim 1 , fossil resins claim 1 , seed claim 1 , barks claim 1 , leaves claim 1 , algae claim 1 , essential oils claim 1 , roots claim 1 , vegetables and fruit.4. The method according to claim 1 , wherein said extraction gas is selected from the group comprising helium claim 1 , neon claim 1 , argon claim 1 , krypton claim 1 , xenon claim 1 , carbon dioxide claim 1 , nitrogen claim 1 , oxygen or mixtures thereof.5. The method according to claim 4 , wherein said extraction gas is selected from the group comprising argon claim 4 , nitrogen claim 4 , carbon dioxide claim 4 , an argon and nitrogen mixture claim 4 , an argon and carbon dioxide mixture claim 4 , a ...

Подробнее
23-01-2014 дата публикации

USE OF A TRADITIONAL CHINESE MEDICINE COMBINATION IN PREPARATION OF ANTI-ENTEROVIRUS 71 DRUG

Номер: US20140023732A1
Принадлежит:

Disclosed is a use of a pharmaceutical composition in preparation of anti-enterovirus 71 agents. 1. A composition used for anti-EV71 or treatment and/or prevention of the diseases induced by EV71 , the composition comprising:4.7% to 70.0% by weight Herba Houttyniae,4.7% to 46.7% by weight Caulis Lonicerae,2.3% to 42.0% by weight Radix Isatidis; and,1.2% to 35.0% by weight Radix Sophorae Tonkinensis.2. The composition of claim 1 , wherein the composition further comprises:{'i': Cyrtomium fortunei', 'Brucea javanica, 'at least of the group selected from , Radix Angelicae Dahuricae, Herba Andrographitis, Herba Taraxaci, Indigo Naturalis, Caulis Sargentodoxae, Rhizoma Paridis, Herba Artemisiae Annuae, Rhizoma Belamcandae, , Herba Menthae Haplocalycis, Radix Platycodi and Radix Glycyrrhizae.'}3. The composition of claim 1 , wherein the composition further comprises:{'i': 'Cyrtomium fortunei', '1.9% to 37.3% by weight ; and,'}1.2% to 35.0% by weight Radix Angelicae Dahuricae, wherein the Herba Houttyniae is 4.7% to 58.4% by weight.4. The composition of claim 3 , wherein the composition further comprises:2.3% to 23.3% by weight Rhizoma Paridis,2.3% to 23.3% by weight Herba Artemisiae Annuae; and,2.3% to 23.3% by weight Rhizoma Belamcandae, wherein the Herba Houttyniae is 9.3% to 46.7% by weight, Caulis Lonicera is 9.3% to 37.3% by weight, Radix Isatidis is 4.7% to 35.0% by weight, Radix Sophorae Tonkinensis is 2.3% to 23.3% by weight, Cyrtomium fortune is 2.3% to 28.0% by weight, Radix Angelicae Dahuricae is 2.3% to 23.3% by weight, and Rhizoma Paridis is 2.3% to 23.3% by weight.5. A method of treating EV71 and diseases induced by EV71 by administering the composition of .6. (canceled)7. The method of claim 5 , wherein the diseases induced by EV71 are selected from the group comprising hand-foot and mouth disease claim 5 , herpangina claim 5 , aseptic meningitis and encephalitis wherein the composition is prepared into granules.8. (canceled)9. (canceled)10Cyrtomium ...

Подробнее
27-02-2014 дата публикации

COMPOSITIONS COMPRISING EXTRACTS OR FRACTIONS DERIVED FROM ANNONA SQUAMOSA FOR THE PREVENTION, TREATMENT OR CONTROL OF INFLAMMATORY AND METABOLIC DISORDERS

Номер: US20140056987A1
Принадлежит: LAILA NUTRACEUTICALS

The invention discloses synergistic composition comprising at least one derived component standardized to acetogenin compound(s) having α,β-unsaturated-γ-methyl-γ-lactone moiety in combination with at least one biologically active ingredient derived from plants, animals or microorganisms such as vitamins, amino acids, minerals, fibers, various plant and herbal extracts for the prevention, treatment, inhibition or controlling inflammation and/or metabolic disorders and other associated or related diseases. The invention further discloses the method of treating inflammation and/or metabolic disorders and other associated or related diseases. 1Annona squamosaBoswellia serrataAndrographis paniculataTerminalia chebulaCurcuma longa. Synergistic composition comprising a biologically effective extract or fraction of , said biologically effective extract comprising from 0.01 to 30% by weight of at least one compound selected from the group consisting of acetogenins having terminal α ,β-unsaturated-γ-methyl-γ-lactone moiety in combination with at least one biologically active ingredient selected from the group consisting of vitamin A , vitamin B 12 , vitamins C , Vitamin D , vitamin E , krill oil , omega-3-fatty acid , selenium , extract standardized to Boswellic acids , extract , extract , extract , magnesium , selenomethionine , selenocysteine , methylselenocycteine and mixtures thereof.3. The herbal composition according to claim 1 , wherein said acetogenins are selected from the group consisting of squamocin C (LI12103) claim 1 , isosquamocin (LI12132) claim 1 , Dieposabadelin (LI12109) claim 1 , squamostatin D (LI12106) claim 1 , squamocin L (LI12107) claim 1 , squamocin J (LI12111) claim 1 , squamocin G (LI12105) claim 1 , 10-hydroxyasimicin (LI12110); compound LI12104 claim 1 , compound LI12114 claim 1 , compound LI12115 claim 1 , compound LI12112 claim 1 , compound LI12113 claim 1 , compound LI12116 and compound LI12117.4. The compositions as claimed claim 1 , wherein ...

Подробнее
27-02-2014 дата публикации

HERBAL POLYPHARMACEUTICAL FOR PREVENTING AND TREATING ATHEROSCLEROSIS

Номер: US20140057004A1
Принадлежит:

Herbal MDR for the prevention and treatment of atherosclerosis which includes a summary of the genus and a summary of the genus in particular, and Comes as a solid, preferably capsules. Herbal composition is obtained by selecting Rhizome and root of blending by centrifugation, and separating the supernatant which mingles with the alcoholic extract of Applies in the prevention and treatment of atherosclerosis, as well as in atherosclerotic Occlusive disease complications such as blockage of coronary arteries and arteries that supply the heart. 1. An herbal composition having a synergy effect between its components and being used in the prevention and treatment of atherosclerotic Occlusive Disease , the herbal composition comprising:{'i': 'Gentiana', 'an extract from a first herb of the genus and'}{'i': 'Hippocratea.', 'an extract of a second herb of the genus'}2. The composition according to claim 1 , wherein the composition is presented as a solid.3. The composition according to claim 2 , wherein the solid is selected from tablets claim 2 , pills claim 2 , capsules claim 2 , pills claim 2 , granules claim 2 , pearls or homeopathic tablets.4. The composition according to claim 3 , wherein the solid is a capsule.5GentianaGentiana acaulis, Gentiana andrewsii, Gentiana bellidifolia, Gentiana catesbaei, Gentiana cruciata, Gentiana dinarica, Gentiana farreri, Gentiana kurroo, Gentiana lutea, Gentiana macrophylla, Gentiana punctata, Gentiana purpurea, Gentiana scabra,Gentiana verna.. The composition according to claim 1 , wherein said first herb of the genus is selected from the group consisting of: and6GentianaGentiana lutea.. The composition according to claim 1 , wherein the first herb of the genus is7HippocrateaHippocratea acapulcensis, Hippocratea acuminate, Hippocratea acutiflora, Hippocratea adophifriderici, Hippocratea affinis Hippocratea celastroides, Hippocratea excelsa,Hippocratea volubilis.. The composition according to claim 1 , wherein said second herb of the ...

Подробнее
27-02-2014 дата публикации

METHODS OF PROCESSING EXTRACTS OF A T. WILFORDII HOOK F. PLANT

Номер: US20140057008A1
Принадлежит:

Products derived from the Hook F (TwHF) plant in the form of extracts are provided that are useful in preventing, treating, or ameliorating a symptom of an inflammatory disorder or an immune disorder, such as an auto-immune disease. Also provided are methods of freeze-drying a TwHF root and/or root portion, methods of debarking a freeze-dried TwHF root and/or root portion, methods of preparing and/or refining extracts in freely flowable solid form from freeze-dried debarked TwHF roots and/or root portions, and methods of using freely flowable solid extracts of TwHF in preventing, treating or ameliorating a symptom of an inflammatory disorder and/or an immune disorder. 1Tripterygium wilfordii. A method of processing a native extract of a Hook F. (TwHF) plant to produce an extract in the form of a freely flowable solid , the method comprising(a) mixing the native extract with an alcohol to produce an extract/alcohol mixture;(b) combining the extract/alcohol mixture with an excipient under vacuum at a temperature of no more than 50° C. to produce a concentrated mixture; and(c) drying the concentrated mixture at a temperature of no more than 55° C. to remove remaining alcohol, thereby producing the extract in the form of a freely flowable solid.2. The method of claim 1 , wherein the native extract is obtained by one or more ethanol extractions from the root of the TwHF plant.3. The method of claim 1 , wherein the native extract is obtained from a freeze-dried debarked root portion of the TwHF plant.4. The method of claim 1 , wherein the excipient is selected from the group consisting of microcrystalline cellulose claim 1 , maltodextrin claim 1 , fumed silica claim 1 , corn starch claim 1 , and magnesium aluminometasilicate.5. The method according to claim 4 , wherein the excipient is microcrystalline cellulose.6. The method according to claim 1 , wherein the drying step is performed under a vacuum establishing an air pressure of no more than 0.2 atmospheres (atm). ...

Подробнее
06-03-2014 дата публикации

Method for preparing dietary supplements

Номер: US20140065245A1
Автор: Pai-Ying Hsu
Принадлежит: Natures Select International Inc

A novel dietary supplement and methods for manufacturing the said dietary supplement are disclosed for promoting healthy cartilages, connective tissues and bones. The dietary supplement of the present invention comprises glucosamine hydrochloride, collagen, and other dietary ingredients. Some ingredients of the dietary supplement of the present invention help to maintain the functions of cartilages, connective tissues and bones. Some ingredients of the dietary supplement of the present invention also exhibit anti-inflammatory properties. Overall, these ingredients of the dietary supplement are beneficial to the health of human and other animals.

Подробнее
20-03-2014 дата публикации

COMPOUNDS USEFUL FOR THE PREVENTION OR TREATMENT OF ACCOMMODATIVE ASTHENOPIA

Номер: US20140079809A1

The use of L-carnitine, in combination with antioxidants such as vitamin E and inorganic elements such as manganese, zinc, sodium and potassium, for the preparation of a physiological supplement or medicament for ophthalmic use, for the prevention or treatment of accomodative asthenopia is disclosed. 1. A method for preventing or treating accomodative asthenopia or ocular fatigue syndrome , comprising administering to a patient in need thereof eye drops comprising an effective amount of L-carnitine or a pharmaceutically acceptable salt thereof.2. Method according to claim 1 , wherein the L-carnitine is in combination with antioxidants and inorganic elements.3. Method according to claim 2 , wherein the antioxidant is Vitamin E and the inorganic elements are selected from the group consisting of manganese claim 2 , zinc claim 2 , sodium and potassium.4. Method according to claim 1 , wherein said accomodative asthenopia or ocular fatigue syndrome is characterized by symptoms selected from the group consisting of: fatigued claim 1 , painful claim 1 , hazy or bleary of the eyes claim 1 , sleepiness and vomitous.5. Method according to claim 1 , wherein said accomodative asthenopia or ocular fatigue syndrome is due to the use of a computer display.6. Method according to claim 1 , wherein the eye drops comprise:2.0% to 4.0% L-carnitine;0.05 to 1.0% Vitamin E;0.01 to 0.1 mg/L Manganese;0.5 to 1.5 mg/L Zinc;5 to 5000 mg/L Sodium; and1 to 1000 mg/L Potassium.7. Method according to claim 1 , in which the pharmaceutically acceptable salt of L-carnitine is selected from the group consisting of chloride claim 1 , bromide claim 1 , orotate claim 1 , aspartate claim 1 , acid aspartate claim 1 , acid citrate claim 1 , magnesium citrate claim 1 , phosphate claim 1 , acid phosphate claim 1 , fumarate and acid fumarate claim 1 , magnesium fumarate claim 1 , lactate claim 1 , maleate and acid maleate claim 1 , oxalate claim 1 , acid oxalate claim 1 , pamoate claim 1 , acid pamoate claim ...

Подробнее
27-03-2014 дата публикации

Pharmaceutical Composition and Methods for Modulating Immune System, Preventing, Pretreating and/or Treating Cancers

Номер: US20140086951A1
Автор: HAN Quanbin
Принадлежит: HONG KONG BAPTIST UNIVERSITY

This invention provides a pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from Radix Astragali, Radix Codonopsis, , or mixtures thereof, and their extraction process. The present invention further relates to a method of modulating immune system by applying said pharmaceutical composition to a subject suffering from cancers, and a method of preventing and/or pretreating and/or treating cancers in the subject, where said method comprises applying said pharmaceutical composition before/during chemotherapy. 1Ganoderma sinense. A pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from Radix Astragali , Radix Codonopsis , , or mixtures thereof.2. The pharmaceutical composition according to claim 1 , wherein the at least one polysaccharide has a molecular weight in the range of 500-2 claim 1 ,500 kDa claim 1 , 600-2 claim 1 ,000 kDa claim 1 , or 700-1 claim 1 ,900 kDa.3. The pharmaceutical composition according to claim 1 , wherein the at least one polysaccharide comprises one or more constituents selected from the group of glucose claim 1 , galactose claim 1 , mannose claim 1 , rhamnose claim 1 , arabinose claim 1 , their dextrorotary and levorotary compounds claim 1 , and combinations thereof.4. The pharmaceutical composition according to claim 3 , wherein any two of the constituents of the at least one polysaccharide is in the molar ratio ranging from 1:30 to 30:1 claim 3 , 1:20 to 20:1 claim 3 , or 1:10 to 10:1.5. The pharmaceutical composition according to claim 3 , wherein the at least one polysaccharide comprises glucose claim 3 , galactose and mannose as the constituents in the molar ratio of 4.7:27.1:1.0.6. The pharmaceutical composition according to claim 3 , wherein the at least one polysaccharide comprises rhamnose claim 3 , arabinose claim 3 , glucose claim 3 , galactose and galacturonic acid as the constituents in the molar ratio of 0.03:1.00:0.27:0. ...

Подробнее
27-03-2014 дата публикации

PREPARATION METHOD FOR EXTRACTIVE OF JINXUAN HEMORRHOID WASHING POWDER BOTANICALS

Номер: US20140087010A1

The present invention discloses a preparation method for extractive of Jinxuan Hemorrhoid Washing Powder botanicals comprises the steps: A, honeysuckle, schizonepeta, and purslane in the prescription of Jinxuan Hemorrhoid Washing Powder are mixed, ground, and passed through a mesh; the medicinal powder obtained from supercritical extraction is soaked in alcohol, then undergoes percolation extraction, and the percolate is collected; B, the alcohol percolate is concentrated, left stand, and suction filtrated to obtain a filtrate; C, the filtrate macroporously adsorpts to a resin column at a flow velocity, is then removed of to impurity by water washing, and undergoes elution with alcohol to obtain an alcohol eluent; D, alcohol is recovered from the eluent, the remaining liquid is concentrated, and the concentrated liquid is dried to obtain the extractive of Jinxuan Hemorrhoid Washing Powder botanicals. The method is simple and produces high active substance content at a lower production cost and energy consumption. The total content of flavones, saponins, and organic acids exceeds 70%. The extractive has substantial anti-inflammatory and pain relieving effects. 1. A preparation method for extractive of Jinxuan Hemorrhoid Washing Powder botanicals , comprising the following steps:(a) The three flavors of botanicals—honeysuckle, schizonepeta, and purslane in the prescription of Jinxuan Hemorrhoid Washing Powder are mixed at a weight ratio of 3:4:3, ground, and passed through a 30-50 mesh, the medicinal powder obtained from supercritical extraction is added with an alcohol aqueous solution with a weight of 2-4 times that of said medicinal powder and a volume ratio of 30˜90% and soaked for 20-30 hours, and then an alcohol aqueous solution with a volume ratio of 30˜90% is added to make the weight of the alcohol aqueous solution with a volume ratio of 30˜90% equal to 6˜14 times the weight of said medicinal powder, percolation extraction is underwent with a flow velocity of ...

Подробнее
03-04-2014 дата публикации

FORMULATION FOR TREATMENT OF DRY MOUTH AND MOUTH SORES

Номер: US20140093582A1
Автор: Qian Jin
Принадлежит: Golden Pearl Investment LLC

Serum compositions for application to endothelial tissue are described which contain an amniotic fluid extract in combination with embryonic stem cells. Formulations containing the serum composition are also described. The serum compositions and formulations may be used to treat conditions of the mouth such as dry mouth and mouth sores. 1. A serum composition comprising amniotic fluid and homogenized embryo mixed at a ratio of 70-100% amniotic fluid with 0-30% homogenized embryo , obtained from a chicken egg incubated for a period of 5-14 days after fertilization.2. The composition of claim 1 , wherein the incubation period is 7-8 days.3centella asiatica,. A formulation comprising the serum composition of claim 1 , aloe vera claim 1 , calendula extract claim 1 , and St. John's wort extract.4. The formulation according to further comprising at least two additional ingredients selected from the group consisting of hyaluronic acid claim 3 , DL-panthenol claim 3 , vegetable glycerin claim 3 , gluconodeltaloactone claim 3 , sodium benzoate claim 3 , licorice root extract claim 3 , niacinamide claim 3 , green tea extract claim 3 , olive leaf extract claim 3 , leucidal liquid claim 3 , goji berry extract claim 3 , salts claim 3 , and vitamin E.5. The formulation according to claim 4 , wherein the salts are selected from the group consisting of NaCl claim 4 , KCl claim 4 , NaHPO claim 4 , and KHPO.6. A method of treating dry mouth comprising administering the formulation of to a subject in need thereof.7. The method of claim 6 , wherein the formulation is administered as a spray into the mouth.8. The method of claim 7 , wherein the spray or pump is administered as needed.9. A method of treating a mouth sore claim 3 , comprising administering the formulation of to a subject in need thereof.10. The method of claim 9 , wherein the mouth sore is on the lips claim 9 , cheek claim 9 , tongue claim 9 , gums claim 9 , hard palate claim 9 , soft palate claim 9 , mouth floor claim 9 ...

Подробнее
03-04-2014 дата публикации

Plant extracts for treating neurodegenerative diseases

Номер: US20140093591A1
Принадлежит: Finzelberg GmbH and Co KG

The invention relates to the use of ironwort extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases.

Подробнее
10-04-2014 дата публикации

DOSAGE FORMS OF ACTIVE INGREDIENTS CONTAINING HYDROXYSTILBENE FOR TREATING MENOPAUSAL COMPLAINTS

Номер: US20140099368A1
Принадлежит:

The invention provides novel hydroxystilbene-containing dosage forms, processes for producing these dosage forms and the use thereof for the treatment of menopausal symptoms in women, juvenile oligomenorrhea and dysmenorrhea, primary and secondary amenorrhea or endometritis. 1. A solid dosage form comprising an active-ingredient-containing solid core with a pharmaceutically acceptable carrier and an active ingredient content of about 1 to 20% by weight , based on the total weight of the core , wherein the active ingredient is a hydroxystilbene-containing active ingredient or a hydroxystilbene-containing active ingredient combination selected the group consisting of precursors of resveratrol and piceatannol , resveratrol , piceatannol , stereoisomeric forms thereof and functional derivatives thereof , in each case in the form of their salts or in the phenol form.2Rheum rhaponticum.. The solid dosage form as claimed in claim 1 , wherein the active ingredient or the active ingredient combination is obtainable from roots of3. The solid dosage form as claimed in claim 1 , where the active ingredient combination substantially comprises rhaponticin and deoxyrhaponticin in a ratio of about 2:28 to 28:2 by weight.4. The solid dosage form as claimed in claim 1 , wherein the active ingredient combination substantially consists of approximately 60-66% by weight rhaponticin claim 1 , 30-35% by weight deoxyrhaponticin claim 1 , 0-2% by weight rhapontigenin; and 0-2% by weight deoxyrhapontigenin.5. The solid dosage form as claimed in claim 1 , wherein the total active ingredient content is about 2 to 20 mg per dose unit.6. The solid dosage form as claimed in claim 1 , wherein the core is lactose-free core.7. The solid dosage form as claimed in in the form of a pill claim 1 , of a tablet claim 1 , of an extrudate or of granules.8. The solid dosage form as claimed in claim 1 , which has a gastro-resistant coating.9. The solid dosage form as claimed in claim 8 , wherein the coating ...

Подробнее
04-01-2018 дата публикации

Product and Method for Providing Enrichment and Facilitating Expression of Natural Behaviors in Pigs

Номер: US20180000129A1
Принадлежит:

The present invention relates to a formulation that can be utilised to facilitate expression of natural behaviour in pigs, and in particular sows and weaners and a method which utilises the formulation for the same. 1. A composition comprising of molasses , insoluble fibre , triglyceride oil and salt.2. A composition according to which further comprises a setting agent or combination thereof.3. A composition according to or which is presented as a solid or semi-solid composition.4. A composition according to which is presented as a solid form.5. A composition according to which is presented as a block composition.6. A composition according to any one of to wherein the composition comprises:a) about 40% to about 70% w/w molasses;b) about 10% to about 30% w/w insoluble fibre;c) about 1% to about 5% w/w triglyceride oil; andd) about 2% to about 10% w/w salt.7. A composition according to wherein the composition comprises:a) about 40% to about 70% w/w molasses;b) about 10% to about 30% w/w insoluble fibre selected from maize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean or soybean meal, sugar beet or beet pulp, sugarcane, tobacco, barley and oilseed rape;c) about 1% to about 5% w/w triglyceride oil selected from aceituno oil, almond oil, araehis oil, babassu oil, blackcurrant seed oil, borage oil, buffalo ground oil, candlenut oil, canola oil, castor oil, coconut oil, coffee seed oil, corn oil, cottonseed oil, crambe oil, evening primrose oil, grapeseed oil, groundnut oil, hemp seed oil, kapok seed oil, linseed oil, mustard seed oil, olive oil, palm oil, palm kernel oil, peanut oil, poppy seed oil, rapeseed oil, rice bran oil, safflower oil, sesame oil, shark liver oil, shea nut oil, soybean oil, sunflower oil, tea seed oil, tobacco seed oil, vermonia oil, vegetable oil and wheat germ oil; andd) about 2% to about 10% w/w of salt selected from sodium chloride and sodium nitrite.8. A composition according to any one of to where in ...

Подробнее
06-01-2022 дата публикации

Composition comprising elderberry extract as effective component for preventing, treating, or alleviating andropause syndrome

Номер: US20220000954A1
Автор: Hyun Seok Kong
Принадлежит: Kosa Bio Inc

The present invention relates to a composition comprising an elderberry extract as an effective component for preventing, treating, or alleviating andropause syndrome, wherein the elderberry extract of the present invention increases testosterone secretion in sperm cells and andropause syndrome animal models, and thus can be usefully employed as a pharmaceutical or food composition for preventing, treating or alleviating andropause syndrome.

Подробнее
06-01-2022 дата публикации

NUTRITIONAL SUPPLEMENTS FOR ANIMAL HEALTH AND DEVELOPMENT

Номер: US20220000963A1
Автор: PUSILLO GARY
Принадлежит:

Novel nutritional compositions supporting health and growth in mature and young animals are disclosed. The compositions are useful for the feeding of animals, particularly those used for food, performance animals, such as horses, and companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective not only in supporting the growth and health but also in supporting and stimulating the immune system, and in mitigating undesirable infections. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and combined with and of a number health supporting ingredients, especially fatty acids which in combination with the peptides provide significantly enhanced health benefits. 1. A nutritional health supplement for increasing secretory immunoglobulin A (sIgA) in companion and herd animals , the supplement comprising essential fatty acid ingrained sprouted grain seeds and a protein component obtained from enzymatic proteolysis of fermented milk or colostrum.2. The supplement of wherein the sprouted seeds are selected from fenugreek claim 1 , flax claim 1 , rice claim 1 , echium claim 1 , wheat claim 1 , oat claim 1 , barley claim 1 , corn claim 1 , and soy.3. The supplement of wherein the sprouted seeds are germinated flax seeds.4. The supplement of wherein the essential fatty acid is selected from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).5. The supplement of wherein the amount of ingrained sprouted grain seed is 1-10% by weight.6. The supplement of wherein the protein component (biopeptide 1111) comprises a substantially pure mixture of α-lactoglobulin claim 1 , β-globulin claim 1 , albumin and immunoglobulins.7. The supplement of wherein the protein component is a 70-100% by weight proline rich polypeptide mixture (PRP) separated from fermented defatted milk.8Ruminococcus flavefaciensButyrivibrio fibrisolvensFibrobacter succinogenesRuminococcus ...

Подробнее
05-01-2017 дата публикации

METHODS OF APPLYING A HIGH DOSE OF A SKIN CARE ACTIVE TO SKIN WITH IMPROVED SENSORY BENEFITS TO THE SKIN

Номер: US20170000696A1
Принадлежит:

A method of applying a high dose of a skin care active by the step of applying to human skin a liquid foamable composition that has from about 0.5% to about 7%, by weight, of surfactants that are cationic surfactants, nonionic surfactants, and mixtures thereof. The foamable composition contains from about 1% to about 15%, by weight, of a fatty alcohol, from about 5% to about 30%, by weight, of a skin care active, and water. The skin care active is preferably selected from the group consisting of niacinamide, hexyldecanol, a peptide, panthenol, undeylenoyl phenylalanine, retinyl propionate and mixtures thereof. 1. A method of applying a high dose of a skin care active comprising the step of applying to human skin an effective amount of a liquid foamable composition comprising:from about 0.5% to about 7%, preferably from about 0.5% to about 5%, by weight, of a surfactant selected from the group consisting of cationic surfactants, nonionic surfactants, and mixtures thereof;from about 1% to about 15%, preferably, from about 2% to about 7%, by weight, of a fatty alcohol;from about 5% to about 30%, preferably, from about 12% to about 25%, by weight, of a skin care active, wherein the skin care active is preferably selected from the group consisting of niacinamide, hexyldecanol, a peptide, panthenol, undeylenoyl phenylalanine, retinyl propionate and mixtures thereof; andwater.2. The method of applying a high dose of a skin care active of comprising from about 20% to about 92% claim 1 , preferably claim 1 , from about 40% to about 90% claim 1 , and more preferably claim 1 , from about 50% to about 85% claim 1 , by weight claim 1 , of water.3. The method of applying a high dose of a skin care active of or claim 1 , comprising from about 5% to about 50% claim 1 , by weight claim 1 , of a polyol humectant claim 1 , wherein the polyol humectant preferably contains at least 50% glycerin claim 1 , and more preferably the polyol humectant contains at least 75% glycerin.4. The ...

Подробнее
04-01-2018 дата публикации

PREPARATION FOR PROTECTING AGAINST EXTRINSIC AND INTRINSIC SKIN AGING

Номер: US20180000722A1
Принадлежит:

Disclosed is a cosmetic or dermatological preparation which comprises one or more extracts of (purple saxifrage) and/or one or more extracts of (alpine snowbell). The use of these extracts to combat extrinsic and intrinsic skin aging is likewise described. 1Soldanella alpina. A cosmetic or dermatological preparation , wherein the preparation is suitable for topical application to human skin and for cosmetic and/or dermatological use , is present as at least one of a dispersion , gel , aqueous and/or alcoholic solution , serum , oil , tincture , ointment , salve or wipe impregnation media and comprises , based on a total weight of the preparation , from 0.0001% to 15% by weight of (i) one or more extracts of , as well as one or more components selected from fats , oils , waxes , moisturizing and/or humectant substances , alcohols , polyols , polymers , electrolytes , organic solvents , silicones , foam stabilizers , substances for preventing foaming , dyes , coloring pigments , thickeners.2Saxifraga oppositifolia.. The preparation of claim 1 , wherein the preparation further comprises from 0.0001% to 15% by weight of (ii) one or more extracts of3. The preparation of claim 2 , wherein the preparation comprises from 0.0001% to 1% by weight of (i) and/or from 0.0001% to 1% by weight (ii).4. The preparation of claim 1 , wherein (i) comprises at least one water-soluble extract obtained by hydro-alcoholic extraction of plant material.5. The preparation of claim 4 , wherein the plant material comprises plant leaves and/or plant stems.6. The preparation of claim 1 , wherein (i) comprises at least one oil-soluble extract obtained by supercritical fluid extraction of plant material.7. The preparation of claim 6 , wherein the plant material comprises plant leaves and/or plant stems.8. The preparation of claim 1 , in which all of the one or more extracts (i) are water-soluble or all of the one or more extracts (i) are oil-soluble.9Chlamydocapsa. The preparation of claim 1 , ...

Подробнее
05-01-2017 дата публикации

Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin

Номер: US20170000711A1
Принадлежит: Procter and Gamble Co

A liquid foamable composition that has from about 0.5% to about 7%, by weight, of surfactants that are cationic surfactants, nonionic surfactants, and mixtures thereof. The foamable composition contains from about 1% to about 15%, by weight, of a fatty alcohol, from about 5% to about 30%, by weight, of a skin care active, and water. The skin care active is preferably selected from the group consisting of niacinamide, hexyldecanol, a peptide, panthenol, undeylenoyl phenylalanine, retinyl propionate and mixtures thereof.

Подробнее
07-01-2021 дата публикации

COMPOSITON FOR PREVENTING OR TREATING OSTEOPOROSIS

Номер: US20210000900A1
Автор: Kim Hong Sik
Принадлежит:

The present invention relates to a composition for preventing or treating osteoporosis, comprising a extract and a extract, and it is an object of the present invention to provide the composition for preventing or treating osteoporosis, which is capable of increasing bone formation and inhibiting bone resorption. In addition, it is another object of the present invention to provide the composition for preventing or treating osteoporosis, which increases bioaffinity and has no side effects by comprising a extract and a extract, which are natural products, thereby stably exhibiting an effect of preventing or treating osteoporosis. 1Gentiana scabraSambucus williamsii. A composition comprising a extract and a extract.2Gentiana scabraSambucus williamsii. The composition according to claim 1 , wherein the mixing weight ratio of the extract and the extract is 1:0.1 to 10.3Gentiana scabraSambucus williamsii. The composition according to claim 1 , wherein the composition comprises the extract and the extract in an amount of 0.001 to 100% by weight claim 1 , based on the total weight of the total composition.4Gentiana scabraSambucus williamsii. The composition according to claim 1 , wherein the extract and the extract are extracted by hot water extraction.5. The composition according to claim 1 , wherein the composition improves expression of a gene related to bone formation.6. The composition according to claim 5 , wherein the gene related to bone formation is one or more gene selected from the group consisting of ALP claim 5 , osteocalcin claim 5 , BMP claim 5 , TGF-β claim 5 , and osteoprotegerin.7. The composition according to claim 1 , wherein the composition inhibits expression of a gene related to bone resorption.8. The composition according to claim 7 , wherein the gene related to bone resorption is one or more gene selected from the group consisting of NF-kB claim 7 , c-FOS claim 7 , NFATC-1 claim 7 , Cathepsin K claim 7 , and MMP-9.9. A method of preparing the ...

Подробнее
07-01-2016 дата публикации

Gargle Method to Reduce the Duration of Common Cold Symptoms

Номер: US20160000826A1
Автор: Brown Amy C
Принадлежит:

A method of reducing the presence, duration, severity, or symptoms of the common cold entails the administration of a nonalcoholic antiviral remedy to a subject in need of such treatment, preferably in the form of a gargle. 1. A method of treating a patient to reduce the duration or symptoms of the common cold , comprising administering by a gargling method an aliquot of an herbal containing at least one agent selected from the group consisting of antivirals , astringents , acids , antibiotics , minerals , salts , and antimicrobials to a patient in need of such treatment.2. A method of treating a patient to reduce the duration or symptoms of the common cold , comprising administering by the oral route of administration an effective amount of a substance selected from the group consisting of hydrogen peroxide , baking soda , garlic , cayenne pepper , zinc , vinegar , citric acid , malic acid , oxalic acid , benzoic acid , quinic acid , tannic acid , ginger extract , olive whole leaf , fennel , eucalyptus or ascorbic acid effective to treat said patient.3. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises hydrogen peroxide.4. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises vinegar.5. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises ascorbic acid.6. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises food grade acids (citric claim 2 , malic claim 2 , oxalic claim 2 , benoic claim 2 , quinic claim 2 , tannic claim 2 , the unique combination of ingredients found in fresh ginger claim 2 , and any other food grade acid).7. The method of claim 1 , wherein the nonalcoholic claim 1 , antiviral remedy comprises citrus fruit (orange claim 1 , mandarin claim 1 , lemon claim 1 , lime claim 1 , etc.).8. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises honey.9. The method of claim 2 , wherein the ...

Подробнее
07-01-2016 дата публикации

A COMPOSITION FOR IMPROVING JOINT HEALTH, OR FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS

Номер: US20160000844A1
Принадлежит:

The present invention relates to a composition for helping with joint health or preventing, alleviating or treating rheumatoid arthritis and osteoarthritis, which is based on the results of tests conducted using an inflammatory cell model, an osteoarthritis animal model and an acute arthritis animal model. 1. A composition for helping with joint health or preventing , alleviating or treating rheumatoid arthritis and osteoarthritis , which contains , as an active ingredient:an extract mixture obtained by extracting each of Kalopanacis Cortex, Chaenomelis Fructus, Angelicae Gigantis, Zingiberis Rhizoma Crudus, Raphani Semen and Saururi Herba to prepare extracts, and mixing the extracts with one another at a mixing ratio of 150-250 parts by weight of the Kalopanacis Cortex extract: 650-750 parts by weight of the Chaenomelis Fructus extract: 650-750 parts by weight of the Angelicae Gigantis extract: 50-150 parts by weight of the Zingiberis Rhizoma Crudus extract: 50-150 parts by weight of the Raphani Semen extract: 150-250 parts by weight of the Saururi Herba extract; ora dry extract mixture obtained by drying each of the extracts and mixing the dried extracts with one another at the above mixing ratio; or a mixed extract obtained by mixing Kalopanacis Cortex, Chaenomelis Fructus, Angelicae Gigantis, Zingiberis Rhizoma Crudus, Raphani Semen and Saururi Herba with one another at the above mixing ratio to prepare a mixture, and extracting the mixture.2. The composition of claim 1 , which has effects on inhibition of inflammatory cytokines and matrix metalloproteinases (MMPs) claim 1 , relief of inflammation and pain claim 1 , enhancement of activity of cartilage formation factors claim 1 , and normalization of a joint structure.3. The composition of claim 1 , wherein a number of times the extraction is performed when each of the extracts or mixed extract is prepared is two or more.45-. (canceled)6. A pharmaceutical composition for alleviating or treating rheumatoid ...

Подробнее
07-01-2016 дата публикации

COMPOSITION FOR PREVENTING CANCER AND TREATING CANCER AND INTENSIFYING THE EFFECTS OF OTHER ANTICANCER DRUGS

Номер: US20160000856A1
Автор: Tsai Hsiu-Hsien
Принадлежит:

This invention relates to a composition derived from Chinese herbal medicines, medicinal plants and extracts thereof, and to its use for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs. More specifically, the composition of the present invention is derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption. The composition of the invention is obtained through specific techniques and has revealed good cytotoxicities on Malignant Melanoma Cells, Prostate Cancer Cells and Colon Cancer Cells, Lung Cancer Cells, Stomach Cancer Cells, Breast Cancer Cells and Liver Cancer Cells. The composition of the invention has also revealed obvious intensifying the effects of other anticancer drugs. Cancer presents special problems to the medical community which the present invention address, 1. A method for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs , said method is a plant aqueous extract comprises PRUNELLAE SPICA , SCUTELLARIAE BARBATAE HERBA , ANTRODIA CAMPHORATA , CURCUMAE RHIZOMA , PAEONIAE SUFFRUTICOSAE CORTEX , PATRINIAE HERBA , IXERIS HERBA and PHELLINUS LINTEUS extracts.2. The method according to wherein the weight ratio of PRUNELLAE SPICA:SCUTELLARIAE BARBATAE HERBA:ANTRODIA CAMPHORATA:CURCUMAE RHIZOMA:PAEONIAE SUFFRUTICOSAE CORTEX:PATRINIAE HERBA:IXERIS HERBA:PHELLINUS LINTEUS is about(0.5˜1.5):(0.5˜1.5):(0.5˜1.5):(0.5˜1.5):(0.5˜1.5):(0.5˜1.5):(0.5˜1.5):(0.5˜1.5).3. The method according to wherein said therapeutically effective amount is 0.4 to 120 grams per day.4. The method according to wherein the composition is administered to the subject by orally or nasally or cutaneously or parentally or anally or virginally or via eye or via ear or by spray inhalation or by implanted reservoir or operation or acupuncture.5. The method according to wherein said plant aqueous extract is in a form selected from the group consisting of ...

Подробнее
05-01-2017 дата публикации

Prognostic and Diagnostic Methods and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer

Номер: US20170000836A1
Принадлежит:

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a known or discovered treatment regimen along with periodic doses of an herbal combination including Sheng Di Huang, Da Huang or Jin Yin Hua or combinations thereof. 1. A method of treating scalp psoriasis , dermatitis , atopic dermatitis , eczema , herpes , shingles , rheumatoid arthritis (RA) , arthritic psoriasis/psoriatic arthritis , Alzheimer's , Parkinson's , irritable bowel syndrome (IBS) , colitis , prostitis , vasculitis , osteoarthritis , seborrheic dermatitis , acne , colitis , skin lesions , diabetes , hypertension , allergies , asthma , capuche sarcoma , autoimmune , inflammation , dermatologic , cardiovascular , metabolic syndrome , hypotension , coronary artery disease , depression , lupus , sarcoidosis , muscular sclerosis , crohn's disease , UV exposure , burns , warts , dandruff , seborrheic dandruff , chronic inflammation , seborrhea , keratosis , alopecia , hirsutism , capitis , melanoma or non-melanoma skin cancer , basal cell cancer (BCC) , squamous cell cancer (SCC) , scleroderma , dermatofibrosarcoma protuberans , Merkel cell carcinoma , Kaposi's sarcoma , keratoacanthoma , spindle cell tumors , sebaceous carcinomas , microcystic adnexal carcinoma , Paget's disease of the breast , atypical fibroxanthoma , leiomyosarcoma , and angiosarcoma , Marjolin's ulcers , kidney failure , nerve damage caused by a skin condition , or skin burrowing mites , or a skin ailment , lesion or sore , particularly of the scalp and also for other skin regions affected by an ailment that is susceptible to topical or hair treatment , as well as hair fall or hair loss conditions , or combinations thereof , comprising:measuring an elevated level or a low level or a combination of levels of one or more inflammatory cytokines, growth factors; cytokine receptors; ligand to surface markers, chemokines, ...

Подробнее
05-01-2017 дата публикации

Prognostic and Diagnostic Kits and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer

Номер: US20170000837A1
Принадлежит:

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a known or discovered treatment regimen along with periodic doses of an herbal combination including Sheng Di Huang, Da Huang or Jin Yin Hua or combinations thereof. 1. A method of treating scalp psoriasis , dermatitis , atopic dermatitis , eczema , herpes , shingles , rheumatoid arthritis (RA) , arthritic psoriasis/psoriatic arthritis , Alzheimer's , Parkinson's , irritable bowel syndrome (IBS) , colitis , prostitis , vasculitis , osteoarthritis , seborrheic dermatitis , acne , colitis , skin lesions , diabetes , hypertension , allergies , asthma , capuche sarcoma , autoimmune , inflammation , dermatologic , cardiovascular , metabolic syndrome , hypotension , coronary artery disease , depression , lupus , sarcoidosis , muscular sclerosis , crohn's disease , UV exposure , burns , warts , dandruff , seborrheic dandruff , chronic inflammation , seborrhea , keratosis , alopecia , hirsutism , capitis , melanoma or non-melanoma skin cancer , basal cell cancer (BCC) , squamous cell cancer (SCC) , scleroderma , dermatofibrosarcoma protuberans , Merkel cell carcinoma , Kaposi's sarcoma , keratoacanthoma , spindle cell tumors , sebaceous carcinomas , microcystic adnexal carcinoma , Paget's disease of the breast , atypical fibroxanthoma , leiomyosarcoma , and angiosarcoma , Marjolin's ulcers , kidney failure , nerve damage caused by a skin condition , or skin burrowing mites , or a skin ailment , lesion or sore , particularly of the scalp and also for other skin regions affected by an ailment that is susceptible to topical or hair treatment , as well as hair fall or hair loss conditions , or combinations thereof , comprising:measuring a level or combination of levels of one or more of IL-5, IL-13, IL-17, IL-23, TNF-α, IL-6, IL-7, IL-13, GMCSF, MCP-1, IL-9, IL-1-β, IL-1-RA, IL-8, IL-9, IL-10, IL-12, IL-19, IL- ...

Подробнее
01-01-2015 дата публикации

COMPOSITION AND A METHOD FOR WOUND HEALING

Номер: US20150004263A1
Принадлежит:

A herbal composition for wound healing is disclosed. The herbal composition comprises an extract of honeysuckle and an extract of mint in a weight ration of 1:2 to 2:1. The herbal composition further comprises a medical acceptable excipient. 1. A herbal composition comprising an extract of honeysuckle and an extract of mint in a weight ratio of 1:2 to 2:1.2. The herbal composition as claimed in claim 1 , wherein the weight ratio of the extract of honeysuckle and the extract of mint is 1:1.3. The herbal composition as claimed in claim 1 , wherein the extract of honeysuckle is an ethanolic extract via 50% ethanol.4. The herbal composition as claimed in claim 1 , wherein the extract of mint is a water extract of mint.5. The herbal composition as claimed in claim 1 , wherein the herbal composition further comprises a medical acceptable excipient.6. The herbal composition as claimed in claim 5 , wherein the herbal composition comprises 5 wt % of the extract of honeysuckle and 5 wt % of the extract of mint.7. The herbal composition as claimed in claim 5 , wherein the medical acceptable excipient is a polyethylene glycol.8. The herbal composition as claimed in claim 7 , wherein the polyethylene glycol has a molecular weight between 200-10000 kDa.9. A method for wound healing claim 5 , said method comprising administrating an effective amount of the herbal composition as claimed in to a target in need thereof.10. A method for wound healing as claimed in claim 9 , wherein the effective amount of the herbal composition is 0.75 kg/per mof wound area. 1. Field of the InventionThe present invention relates to a composition and, more particularly, to a herbal composition for wound healing. The present invention further relates to a method for wound healing by administrating the herbal composition to a target in need.2. Description of the Related ArtWounds comprising crush wounds, cuts, incisions, squeeze wounds, stab wounds or wounds due to surgery, plastic surgery or chronic ...

Подробнее
13-01-2022 дата публикации

PLANT TISSUE-DERIVED NANOPARTICLES AND FOOD POWDERS

Номер: US20220008349A1
Принадлежит: PSIGRYPH INC.

Provided herein are nanoparticles including self-assembled cellular components derived from a homogenized plant tissue. Also provided are food powders and other related compositions. Methods for preparing such nanoparticles and food powders, as well as uses thereof in the treatment or prevention of diseases or disorders in a subject and/or as delivery vehicles are also described. 1. A nanoparticle comprising self-assembled cellular components derived from a homogenized plant tissue , the cellular components comprising one or more structural carbohydrates or cleavage products thereof , wherein lipids are not a structural component of the nanoparticle.2. The nanoparticle of claim 1 , wherein the nanoparticle is substantially lipid-free.3. The nanoparticle of or claim 1 , wherein the nanoparticle comprises pectin claim 1 , hemicellulose claim 1 , peptide and/or protein claim 1 , an organic acid claim 1 , at least one polyphenol claim 1 , cleavage products thereof claim 1 , or any combination thereof.4. The nanoparticle of any one of - claim 1 , wherein the nanoparticle comprises:a pectin-based inner core;an intermediate layer surrounding the inner core, the intermediate layer comprising macromolecules of pectin and hemicellulose and/or cleavage products thereof, polyphenol, and organic acid; anda fibrillated outer layer comprising macromolecular carbohydrate and protein, optionally formed from catabolism during ripening and/or during homogenization of the plant tissue.5. The nanoparticle of or claim 1 , wherein the organic acid comprises malic acid claim 1 , ascorbic acid claim 1 , or both.6. The nanoparticle of any one of - claim 1 , wherein the polyphenol comprises an anthocyanin.7. The nanoparticle of any one of - claim 1 , wherein the cellular components comprise those liberated from the plant tissue during ripening or during homogenization of ripened fruit claim 1 , which are capable of self-assembling into the nanoparticle.8. The nanoparticle of any one of - ...

Подробнее
02-01-2020 дата публикации

Sensor attachment structure

Номер: US20200003656A1
Принадлежит: Nidec Tosok Corp

A sensor case includes a body portion having a circular horizontal section. An upper body 1 includes an accommodation space 4 having a wall surface having a circular horizontal section, and the body portion is inserted in the accommodation space 4 such that the body portion is capable of rotating about a central axis thereof extending in a vertical direction. A stopper 50 is arranged to project in a horizontal direction in an outer circumferential surface of the body portion. A guide groove 51 is arranged to extend in the vertical direction at the wall surface of the accommodation space 4, and is arranged to allow the stopper 50 to move therein. The upper body 1 includes a restricting portion 52 arranged to restrict a vertical movement of the stopper 50.

Подробнее
01-01-2015 дата публикации

Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies

Номер: US20150005382A1
Автор: Chilton Floyd H.
Принадлежит:

The present invention provides methods of identifying a subject as responsive to treatment of an inflammatory disease and/or inflammation with one or more polyunsaturated fatty acids (PUFAs), comprising detecting, in a nucleic acid sample of a subject having an inflammatory disease and/or inflammation, the presence of a C allele at single nucleotide polymorphism (SNP) rs730012 in the leukotriene C4 synthase gene, wherein the presence of said C allele at rs730012 in said nucleic acid sample from the subject indicates that the subject is responsive to treatment of said inflammatory disease and/or inflammation with one or more PUFAs. 1. A method of identifying a subject as responsive to treatment of an inflammatory disease with one or more polyunsaturated fatty acids (PUFAs) , comprising:detecting, in a nucleic acid sample of a subject having an inflammatory disease, the presence of a C allele at single nucleotide polymorphism rs730012,wherein the presence of said C allele at rs730012 in said nucleic acid sample from the subject identifies the subject as being responsive to treatment of said inflammatory disease with one or more PUFAs.2. A method of identifying , within a population of subjects having an inflammatory disease , a subpopulation of subjects having an inflammatory disease that is responsive to treatment with one or more polyunsaturated fatty acids (PUFAs) , comprising:detecting, in a nucleic acid sample from each of said subjects, the presence a C allele at single nucleotide polymorphism rs730012,wherein the subpopulation of subjects having an inflammatory disease that is responsive to treatment with one or more PUFAs comprises those subjects having a C allele at rs730012, thereby identifying, within a population of subjects having an inflammatory disease, a subpopulation of subjects having an inflammatory disease that is responsive to treatment one or more PUFAs.3. A method of identifying a subject as responsive to treatment of inflammation with one or ...

Подробнее
12-01-2017 дата публикации

Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin

Номер: US20170007511A1
Принадлежит: Procter and Gamble Co

A liquid foamable composition that has from about 0.5% to about 7%, by weight, of surfactants that are cationic surfactants, nonionic surfactants, and mixtures thereof. The foamable composition contains from about 1% to about 15%, by weight, of a fatty alcohol, from about 5% to about 30%, by weight, of a skin care active, and water. The skin care active is preferably selected from the group consisting of niacinamide, hexyldecanol, a peptide, panthenol, undeylenoyl phenylalanine, retinyl propionate and mixtures thereof.

Подробнее
12-01-2017 дата публикации

COMPOSITION FOR RELIEVING PAIN, STRESS AND INSOMNIA

Номер: US20170007655A1
Автор: BANSAL Ashvany Kumar
Принадлежит:

The present invention relates to a composition for relieving one or more of the conditions of pain, stress and insomnia comprising , Bees wax and . The present invention also provides a formulation comprising the composition of the present invention as well as method for preparation thereof, uses thereof and method of treatment of one or more of the conditions of pain, stress and insomnia. 115-. (canceled)16Brassica campestrisDryobalanops camphoraBrassica campestrisDryobalanops camphora. A composition comprising , bees wax and , wherein the , bees wax and are active ingredients exhibiting synergistic activities.17Brassica campestrisDryobalanops camphoraBrassica campestrisDryobalanops camphora. A composition comprising oil in the range of 40 to 75 weight parts of the composition , bees wax in the range of 15 to 50 weight parts of the composition and in the range of 1 to 20 weight parts of the composition , wherein the , bees wax and are active ingredients exhibiting synergistic activities.18Brassica campestrisDryobalanops camphora. The composition as claimed in claim 16 , wherein the is 40 to 75 weight parts of the composition claim 16 , bees wax is 15 to 50 weight parts of the composition and is 1 to 20 weight parts of the composition.19Brassica campestrisDryobalanops camphora. The composition as claimed in claim 16 , wherein the is 55 to 65 weight parts of the composition claim 16 , bees wax is 25 to 35 weight parts of the composition and is 3 to 13 weight parts of the composition.20. The composition as claimed in claim 16 , further comprising one or more of oil or perfume or pharmaceutically acceptable excipients.21. The composition as claimed in claim 17 , further comprising one or more natural or synthetic active ingredients and/or pharmaceutically acceptable excipients.22. A formulation comprising the composition as claimed in .23. A formulation comprising the composition as claimed in .24Brassica campestrisBrassica campestrisDryobalanops camphora. A method for ...

Подробнее
12-01-2017 дата публикации

Artcure diffusional patch

Номер: US20170007656A1
Автор: Mehmet SORAR, Tuba ÇALIK

The present invention is a diffusional patch having an oil mixture ( 20 ) providing mechanical treatment support by reducing the edema in volume and in mass by throwing out the liquid inside by means of diffusion effect after entering into the region with edema by means of the diffusion effect and placed into a porous sheath ( 10 ) in microfiber structure, in order to be used in treatment of region with edema which may occur in sports injuries and/or disc hernia ( 50 ); characterized in that said oil mixture ( 20 ), of which the ingredient proportions in weight are given, comprises the below mentioned ingredients and does not comprise water: Ingredient Amount (%) Dextrin Palmitate Derivatives 1-10 Paraffin 1-30 Oleum nigellae sativae (black cumin oil) 0-20 Oleum origani (carvacrol) 0-20 Oleum lauri expressum (laurel oil) 0-30 Oleum chamomillae (chamomile oil) 0-30 Balsamum meccae (balsam oil) 0-30 Styrax liguidus (sweetgum) 0-30 Oleum limonis (lemon oil) 0-10 Oleum rosmarini (rosemary oil) 0-10 Olive oil 0-30 Oleum vitis vinifera 0-10

Подробнее
14-01-2016 дата публикации

Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin

Номер: US20160008266A1
Принадлежит: Avon Products Inc

The present disclosure relates to methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, by application of one or a combination of natural compounds or extracts that stimulate MAGP-1 expression and which improves the appearance of aged and/or photodamaged skin. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof in an amount effective to improve the condition and aesthetic appearance of skin.

Подробнее
14-01-2016 дата публикации

Plant and Animal Extracts and Related Methods

Номер: US20160008417A1
Автор: Christopher VANDECAR
Принадлежит: Individual

The present disclosure is drawn to methods for producing natural extracts utilizing fulvic acid solutions as well as the extracts produced utilizing the disclosed methods. The method provides for selecting natural material(s) for extraction and contacting the natural material with a fulvic acid solution. In some embodiments the contacting can occur by pouring, dripping, sprinkling, submersing, or substantially submersing the natural material with the fulvic acid solution.

Подробнее
11-01-2018 дата публикации

LIPID COMPRISING POLYUNSATURATED FATTY ACIDS

Номер: US20180008568A1
Принадлежит:

The present invention relates to extracted plant lipid, comprising fatty acids in an esterified form. 1113-. (canceled)115. The process of claim 114 , wherein the number of T-DNA molecules claim 114 , comprising the exogenous polynucleotides claim 114 , which are integrated into the genome of the seed is two or three.116. The process of claim 114 , wherein at least one of the promoters operably linked to an exogenous polynucleotide is a conlinin seed storage protein gene promoter.117. The process of claim 114 , wherein the Δ6 desaturase is a Δ6 desaturase whose amino acid sequence is set forth as SEQ ID NO:16 or is provided by Accession No. AAW70159.118. The process of claim 114 , wherein the Δ4 desaturase is a Δ4 desaturase whose amino acid sequence is set forth as SEQ ID NO:41 or is provided by Accession No. AY332747.119Phytophthora sojae. The process of claim 114 , wherein the fungal Δ12 desaturase is a Δ12 desaturase.120. The process of claim 114 , wherein the Δ6 elongase has the amino acid sequence provided by Accession No. AF428243 claim 114 , the Δ5 desaturase has the amino acid sequence provided by Accession No. AF489588 claim 114 , and the Δ5 elongase has the amino acid sequence provided by Accession No. AAV67798.121. The process of claim 114 , wherein at least 70% of the DHA in the seed which is esterified in triacylglycerols (TAG) is esterified at the sn-1 or sn-3 position of the TAG.122. The process of claim 121 , wherein at least 80% of the DHA in the seed which is esterified in triacylglycerols (TAG) is esterified at the sn-1 or sn-3 position of the TAG.123. The process of claim 114 , wherein DHA is present in the seed at a level of about 3% of the total fatty acid content.124. The process of claim 114 , wherein DHA is present in the seed at a level of about 4% of the total fatty acid content.125. The process of claim 114 , wherein DHA is present in the seed at a level of about 5% of the total fatty acid content.126. The process of claim 114 , wherein ...

Подробнее
14-01-2021 дата публикации

REGULATION OF CANCER USING NATURAL COMPOUNDS AND/OR DIET

Номер: US20210008024A1
Принадлежит:

The current invention is directed to a treatment of a proliferative disease comprising administering to a subject in need of such treatment, a composition comprising epigallocatechin-3-gallate (EGCG), curcumin, glucosinolates and, optionally Daikon radish sprout, alone or in combination with providing a ketogenic diet or a modified ketogenic diet to the subject. The invention also provides a composition comprising medium chain triglycerides, Epigallocatechin-3-gallate, curcumin, compositions comprising glucosinolates and/or derivatives thereof, such as glucoraphanin and its breakdown product sulforaphane, (SFN) (which are found at high levels in broccoli sprouts or sprouts of other cruciferous vegetables), and, optionally Daikon radish sprout. 1. A method of treating a subject for a proliferative disease , comprising:a) administering to the subject in need of such treatment, an effective amount of a composition comprising epigallocatechin-3-gallate, a composition comprising curcumin, and a composition comprising glucosinolates and/or derivatives thereof, such as glucoraphanin and/or sulforaphane (SFN), and, optionally, providing a modified ketogenic diet or a ketogenic diet to the subject; orb) providing a modified ketogenic diet or a ketogenic diet to the subject; and, optionally, administering to the subject in need of such treatment, an effective amount of a composition comprising epigallocatechin-3-gallate, a composition comprising curcumin, and a composition comprising glucosinolates and/or derivatives thereof, such as glucoraphanin and/or sulforaphane (SFN).2. The method of claim 1 , wherein the proliferative disease is a cancer.3. The method of claim 2 , wherein the proliferative disease is a cancer selected from the group consisting of Acute Lymphoblastic Leukemia claim 2 , Acute Myeloid Leukemia claim 2 , Adrenocortical Carcinoma claim 2 , AIDS-Related Cancers claim 2 , AIDS-Related Lymphoma claim 2 , Anal Cancer claim 2 , Appendix Cancer claim 2 , ...

Подробнее
14-01-2021 дата публикации

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM

Номер: US20210008176A1
Принадлежит:

The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and magnesium or a salt or complex thereof. The invention also relates to the combination of a sulforaphane or a derivative thereof and magnesium or a salt or complex thereof. The invention also relates to the combination of a broccoli extract or powder and magnesium or a salt or complex thereof. The invention provides compositions and methods relating to these combinations.

Подробнее
27-01-2022 дата публикации

ADDITIVE AND/OR SYNERGISTIC COMBINATIONS OF METFORMIN WITH NUTRACEUTICALS FOR THE PREVENTION, INHIBITION AND TREATMENT OF SARS-COV-2 AND ASSOCIATED COVID-19

Номер: US20220023237A1

Disclosed are compositions of matter, treatments and protocols useful for prevention of SARS-CoV-2 infection, as well as inhibition of viral propagation and acceleration of viral cure. In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of metformin, pterostilbene, nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal at risk of infection with SARS-CoV-2. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients with COVID-19. 1. A method of inhibiting infection with SARS-CoV-2 , suppressing proliferation of SARS-CoV-2 and inducing resolution of SARS-CoV-2 comprising administration of a therapeutic combination comprising: a) Green Tea and/or extract thereof; b) Blueberry and/or extract thereof; c) Nigella Sativa and/or extract thereof; d) broccoli and/or extract thereof and e) metformin2. The method of claim 1 , wherein said green tea extract is epigallocatechin-3-gallate or an analogue thereof.3. The method of claim 1 , wherein said blueberry extract is pterostilebene or an analogue thereof.4. The method of claim 1 , wherein said Nigella Sativa extract is thymoquinone or an analogue thereof.5. The method of claim 1 , wherein said broccoli extract is sulforaphane or an analogue thereof.6. The method of claim 1 , wherein said therapeutic combination is administered at a dosage and frequency sufficient to inhibit viral establishment into the host.7. The method of claim 6 , wherein inhibition of viral establishment into the host is accomplished byenhancement of natural killer cell activity.8. The method of claim 6 , wherein inhibition of viral establishment into the host is accomplished byenhancement of interferon production.9. The method of claim 1 , wherein said ...

Подробнее
27-01-2022 дата публикации

COMPOSITION FOR PREVENTING OR TREATING METABOLIC BONE DISEASES OR MENOPAUSAL SYMPTOMS

Номер: US20220023370A1
Принадлежит:

The present invention relates to a composition for preventing or alleviating metabolic bone diseases or menopausal symptoms, comprising a complex extract of and as an active ingredient. When the present invention is used, metabolic bone disease or menopausal symptoms can be effectively prevented or alleviated without side effects. 1. A pharmaceutical composition for preventing or treating a metabolic bone disease or a menopausal symptom , the composition comprising:{'i': Pueraria lobata', 'Platycodon grandiflorum, '(a) a complex extract of and as an active ingredient; and'}(b) a pharmaceutically acceptable carrier thereof.2Pueraria lobataPlatycodon grandiflorum. The composition of claim 1 , wherein a weight ratio (w/w) of to in the complex extract is 1:20 to 20:1.3. The composition of claim 1 , wherein the extract is a polar organic solvent extract.4. The composition of claim 3 , wherein the polar organic solvent is water claim 3 , an anhydrous or hydrated lower alcohol of 1-4 carbon atoms claim 3 , acetic acid claim 3 , or a mixture thereof.5Pueraria lobataPlatycodon grandiflorum. A food composition for preventing or alleviating a metabolic bone disease or a menopausal symptom claim 3 , the composition comprising a complex extract of and as an active ingredient.6Pueraria lobataPlatycodon grandiflorum. The food composition of claim 5 , wherein a weight ratio (w/w) of to in the complex extract is 1:20 to 20:1.7. The food composition of claim 5 , wherein the extract is a polar organic solvent extract.8. The food composition of claim 7 , wherein the polar organic solvent is water claim 7 , an anhydrous or hydrated lower alcohol of 1-4 carbon atoms claim 7 , acetic acid claim 7 , or a mixture thereof.9. A method for preventing claim 7 , alleviating claim 7 , or treating metabolic bone diseases or menopausal symptoms claim 7 , the method comprising:{'i': Pueraria lobata', 'Platycodon grandiflorum., 'administering to a subject in need thereof, a pharmaceutical composition ...

Подробнее
08-01-2015 дата публикации

SUPERCRITICAL GUGGUL EXTRACTS AND USES THEREOF

Номер: US20150010615A1
Принадлежит:

The subject invention pertains to supercritical carbon dioxide extracts of resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite. 1Commiphora mukul. A composition comprising a supercritical carbon dioxide extract of resin (guggul) , wherein the carbon dioxide is optionally modified by ethanol addition.2. The composition of claim 1 , further comprising an oil (natural or synthetic).3. The composition of claim 2 , wherein the oil comprises one or more medium chain triglycerides.4. The composition of claim 3 , wherein the one or more triglyclerides comprise C8 and C10 fatty acids.5. The composition of claim 3 , wherein the oil comprises triheptanoin.6. The composition of claim 2 , wherein the oil comprises at least one selected from among olive oil claim 2 , chia seed oil claim 2 , soy germ oil claim 2 , pomegranate oil claim 2 , fish oil claim 2 , and seafood oil.7. The composition of claim 1 , wherein the composition contains 0.1%-5% guggulsterone (total E and Z guggulsterones).8. The composition of claim 7 , wherein the composition contains 1.5%-3% guggulsterone (total E and Z guggulsterones).9. The composition of claim 1 , wherein the composition comprises 1.9%-2.1% guggulsterones (by HPLC); 6%-9% phytosterol; essential oil; cembrene; mukulol (allycembrol); and less than 3% ...

Подробнее
10-01-2019 дата публикации

METHOD FOR TREATING DIABETES MELLITUS CAUSED BY PANCREATITIS

Номер: US20190008915A1
Автор: Lee Chen-Yu, LIAO Yan-Chih
Принадлежит:

A therapeutic method for treating diabetes mellitus, particularly diabetes caused by pancreatitis, comprising administering an effective amount of a Chinese herbal medicine to a subject. The Chinese herbal medicine is an extract of a mixture comprising specific amount of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, semen Platycladi, Coptidis Rhizoma, cortex Mori, rhubarb, and Davallia formosana. 1. A method for treating diabetes mellitus caused by pancreatitis , comprising: administering a therapeutically effective amount of a Chinese herbal medicine to a subject in need ,wherein the Chinese herbal medicine is an extract of a first mixture comprising raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, semen Platycladi, Coptis Rhizome, Mori Cortex, Rhubarb, and Davallia formosana.2. The method as claimed in claim 1 , wherein the Chinese herbal medicine is prepared by the following steps:providing raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix. Rehmanniae, semen Platycladi, Coptis Rhizome, Mori Cortex, Rhubarb, and Davallia formosana to form the first mixture;mixing the first mixture with water to obtain a second mixture;decocting the second mixture to obtain a crude extract; andfiltering the crude extract to remove a residue and obtain the Chinese herbal medicine.3. The method as claimed in claim 1 , wherein the Chinese herbal medicine is the extract of the first mixture comprising 4-6 parts by weight of raw oyster shell powder claim 1 , 4-6 parts by weight of raw Os Draconis claim 1 , 7-9 parts by weight of Haematitum claim 1 , 2-4 parts by weight of Magnetitum claim 1 , 4-6 parts by weight of radix Achyranthis Bidentatae claim 1 , 4-6 parts by weight of ...

Подробнее
10-01-2019 дата публикации

Method Of Treatment Of Drug-Resistance Diabetes Mellitus

Номер: US20190008916A1
Автор: Lee Chen-Yu, LIAO Yan-Chih
Принадлежит:

The present invention is directed to a therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires multiple drug resistance, comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi. 1. A method of treatment of drug-resistance diabetes mellitus , comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need;wherein the Chinese herbal medicine is an extract of a first mixture comprising raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi.2. The method as claimed in claim 1 , wherein the Chinese herbal medicine is prepared by the following steps:providing the first mixture;mixing the first mixture and water to form a second mixture;heating the second mixture to obtain a crude extract; andfiltering the crude extract and retaining the liquid, to obtain the Chinese herbal medicine.3. The method as claimed in claim 1 , wherein the first mixture comprising 4-6 parts by weight of raw oyster shell powder claim 1 , 4-6 parts by weight of raw Os Draconis claim 1 , 7-9 parts by weight of Haematitum claim 1 , 2-4 parts by weight of Magnetitum claim 1 , 4-6 parts by weight of radix Achyranthis Bidentatae claim 1 , 4-6 parts by weight of rhizoma Dioscoreae claim 1 , 4-6 parts by weight of radix Paeoniae Rubra claim 1 , 4-6 parts by weight of radix Rehmanniae claim 1 , and 3-5 parts by weight of semen Platycladi.4. The method as claimed in claim 2 , wherein the part by weight of the first mixture is 3.75 gram per part.5Poria, Alisma. The method as claimed in claim 1 , wherein the ...

Подробнее
10-01-2019 дата публикации

Method Of Treatment Of Insulin-Resistance Diabetes Mellitus

Номер: US20190008917A1
Автор: Lee Chen-Yu, LIAO Yan-Chih
Принадлежит:

The present invention is directed to a therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires insulin resistance, comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi. 1. A method of treatment of insulin-resistant diabetes mellitus , comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need;wherein the Chinese herbal medicine is an extract of a first mixture comprising raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi.2. The method as claimed in claim I , wherein the Chinese herbal medicine is prepared by following steps:providing the first mixture;mixing the first mixture and water to form a second mixture;heating the second mixture to obtain a crude extract; andfiltering the crude extract and retaining the liquid, to obtain the Chinese herbal medicine.3. The method as claimed in claim 1 , wherein the Chinese herbal medicine is the extract of the first mixture comprising 4-6 parts by weight of raw oyster shell powder claim 1 , 4-6 parts by weight of raw Os Draconis claim 1 , 7-9 parts by weight of Haematitum claim 1 , 2-4 parts by weight of Magnetitum claim 1 , 4-6 parts by weight of radix Achyranthis Bidentatae claim 1 , 4-6 parts by weight of rhizoma Dioscoreae claim 1 , 4-6 parts by weight of radix Paeoniae Rubra claim 1 , 4-6 parts by weight of radix Rehmanniae claim 1 , and 3-5 parts by weight of semen Platycladi.4. The method as claimed in claim 3 , wherein the part by weight of the first mixture is 3.75 gram per part.5. The method as claimed in ...

Подробнее
27-01-2022 дата публикации

Isolation and characterization of anticancer compound from sesuvium portulacastrum (l.) l.

Номер: US20220024872A1
Принадлежит: Individual

The invention discloses a novel anticancer compound, 3, 4, 5-trimethyl-2-(4-(8-methylnonyl)phenyl)pyridine extracted from Sesuvium portulacastrum (S. portulacastrum) having the structure as represented by Formula (I). The invention also discloses a method of extraction of this anticancer compound, 3, 4, 5-trimethyl-2-(4-(8-methylnonyl)phenyl)pyridine from S. portulacastrum. The invention further relates to characterization of the anticancer compound, 3, 4, 5-trimethyl-2-(4-(8-methylnonyl)phenyl)pyridine and study of its effect on the cancer cell cycle progression and expression of genes involved in apoptosis.

Подробнее
08-01-2015 дата публикации

USAGE OF GUTTIFERONE K, A NATURAL COMPOUND FROM GARCINIA YUNNANENSIS HU ON TREATING HIGH METASTATIC ESOPHAGEAL CANCER

Номер: US20150011646A1
Принадлежит: HONG KONG BAPTIST UNIVERSITY

This invention is related to compounds isolated from various species and method of treating cancer. The present invention provides composition for treating cancer comprising polyprenylated acylphloroglucinol (PPAP) compound. The present invention also provides a composition comprising Guttiferone K for treating esophageal cancer. 2. The composition according to wherein said compound comprising Guttiferone K.3. The composition according to wherein said compound is isolated from a natural plant.4Garcinia. The composition according to wherein said natural plant comprising species.5GarciniaGarcinia yunnanesis. The composition according to wherein said species comprising Hu.6. The composition according to wherein the treated cancer comprising esophageal cancers.7. The composition according to wherein the cancer treatment comprising anti-migration of cancer cells and anti-invasion of cancer cells.8. A use of the composition according to for manufacture of a medicament for cancer treatment.9. The use according to wherein said composition is used as a cancer metastasis inhibitor.10. A method of treating cancer using composition according to by administering said composition to a subject in need of such treatment. This application claims the benefit of U.S. Provisional Patent Application Ser. No. 61/750,969 filed Jan. 10, 2013, disclosure of which is incorporated herein by reference in its entirety.This invention relates to a chemical entity isolated from natural sources for its therapeutic uses. More particularly, it relates to a compound that is naturally occurring in the plant of Hu and its biological activity of anticancer effects.Esophageal cancer is one of the most common malignancies and is associated with a dismal prognosis. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. The present invention provides a natural compound, Guttiferone K, from Hu and method of using ...

Подробнее
03-02-2022 дата публикации

CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE

Номер: US20220030928A1
Принадлежит:

A pouched product adapted for release of a releasable component therefrom is provided herein. The pouched product can include a water-permeable fabric pouch formed so as to define a cavity therein, and a composition contained within the cavity of the water-permeable fabric pouch, the composition including one or more releasable components that are released from the composition under mouth conditions and that are capable of movement through the water-permeable fabric pouch. The composition includes nicotine and at least one particulate non-tobacco material. The pouched product also includes at least one capsule contained within the cavity of the water-permeable fabric pouch, the capsule having a capsule wall surrounding an inner payload comprising at least one botanical. 1. A pouched product adapted for oral use , comprising:a water-permeable fabric pouch formed so as to define a cavity therein;a composition contained within the cavity of the water-permeable fabric pouch, the composition comprising one or more releasable components that are released from the composition under mouth conditions and that are capable of movement through the water-permeable fabric pouch, the composition comprising nicotine and at least one particulate non-tobacco material; andat least one capsule contained within the cavity of the water-permeable fabric pouch, the at least one capsule having a capsule wall surrounding an inner payload comprising at least one botanical.2. The pouched product of claim 1 , wherein the capsule wall comprises a material configured to be broken by shear forces.3. The pouched product of claim 1 , wherein the at least one particulate non-tobacco material comprises microcrystalline cellulose.4. The pouched product of claim 1 , wherein the nicotine is synthetic nicotine.5. The pouched product of claim 4 , wherein the synthetic nicotine is in the form of S(−)-nicotine or a racemic mixture composed predominantly of S(−)-nicotine.6. The pouched product of claim 1 , ...

Подробнее
03-02-2022 дата публикации

Kind of Chinese medicine and microcapsule preparation method suitable for nasopharyngeal carcinoma tumor inhibitor

Номер: US20220031626A1
Принадлежит:

The invention relates to the technical field of traditional Chinese medicine, and discloses a method of traditional Chinese medicine and microcapsule preparation suitable for nasopharyngeal cancer tumor inhibitors. A traditional Chinese medicine suitable for nasopharyngeal cancer tumor inhibitors, including: Hedyotis Diffusa, Scutellaria Barbata, Arrowshaped Tinospora Root, Rehmanniae Radix Preparata, Radix Curcumae, Crotonis Fructus, Leonurus Artemisia, Ramulus Cinnamomi, Forsythiae Fructus, Taraxacum, Radix Platycodonis and White Vinegar. Among them, the raw materials for the weight ratio are as follows: 60 grams of Hedyotis Diffusa, 30 grams of Scutellaria Barbata, 9-12 grams of Arrowshaped Tinospora Root, 18 grams of Rehmanniae Radix Preparata, 19 grams of Radix Curcumae, 7.5 grams of Crotonis Fructus, 10 grams of Leonurus Artemisia, 7-10 grams of Ramulus Cinnamomi, 10 grams of Forsythiae Fructus, 15-30 grams of Taraxacum, 10 g of Radix Platycodonis, and 30 ml of White Vinegar. 1. A Chinese medicine suitable for nasopharyngeal cancer tumor inhibitors , which is characterized in that it comprises: Hedyotis Diffusa , Scutellaria Barbata , Arrowshaped Tinospora Root , Rehmanniae Radix Preparata , Radix Curcumae , Crotonis Fructus , Leonurus Artemisia , Ramulus Cinnamomi , Forsythiae Fructus , Taraxacum , Radix Platycodonis and White Vinegaris and White Vinegar. Among them , the raw materials for the weight ratio are as follows: 60 grams of Hedyotis Diffusa , 30 grams of Scutellaria Barbata , 9-12 grams of Arrowshaped Tinospora Root , 18 grams of Rehmanniae Radix Preparata , 19 grams of Radix Curcumae , 7.5 grams of Crotonis Fructus , 10 grams of Leonurus Artemisia , 7-10 grams of Ramulus Cinnamomi , 10 grams of Forsythiae Fructus , 15-30 grams of Taraxacum , 10 g of Radix Platycodonis , and 30 ml of White Vinegar.2. A preparation method of traditional Chinese medicine microcapsules suitable for nasopharyngeal cancer tumor inhibitors is characterized in that it ...

Подробнее